https://de.pi-multilingual.rt.gw/section/take-home-messages-2676-5281/ 2022-10-27T16:08:48+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2688-5339/ 2022-10-27T22:17:13+00:00 https://de.pi-multilingual.rt.gw/section/why-use-clozapine-2688-5328/ 2022-10-27T22:23:23+00:00 https://de.pi-multilingual.rt.gw/section/managing-clozapine-related-constipation-2688-5330/ 2022-10-27T22:23:23+00:00 https://de.pi-multilingual.rt.gw/section/managing-clozapine-related-orthostasis-2688-5331/ 2022-10-27T22:23:23+00:00 https://de.pi-multilingual.rt.gw/section/managing-clozapine-induced-tachycardia-and-concerns-regarding-qtc-2688-5332/ 2022-10-27T22:23:23+00:00 https://de.pi-multilingual.rt.gw/section/managing-clozapine-related-seizures-2688-5333/ 2022-10-27T22:23:23+00:00 https://de.pi-multilingual.rt.gw/section/medications-for-managing-clozapine-related-seizures-and-stuttering-2688-5334/ 2022-10-27T22:23:23+00:00 https://de.pi-multilingual.rt.gw/section/vte-and-antipsychotics-2688-5336/ 2022-10-27T22:23:24+00:00 https://de.pi-multilingual.rt.gw/section/managing-vte-during-clozapine-therapy-2688-5337/ 2022-10-27T22:23:24+00:00 https://de.pi-multilingual.rt.gw/section/managing-constipation-in-a-woman-on-clozapine-2688-5338/ 2022-10-27T22:23:24+00:00 https://de.pi-multilingual.rt.gw/section/drug-metabolism-enzyme-induction-and-inhibition-2039-4024/ 2022-10-29T15:54:18+00:00 https://de.pi-multilingual.rt.gw/section/screening-for-bipolar-disorder-2335-4462/ 2022-11-02T17:07:39+00:00 https://de.pi-multilingual.rt.gw/section/managing-clozapine-related-sialorrhea-2688-5329/ 2022-11-08T17:21:47+00:00 https://de.pi-multilingual.rt.gw/section/vilazodone-the-essentials-2343-4476/ 2022-11-09T13:35:58+00:00 https://de.pi-multilingual.rt.gw/section/adhd-pharmacotherapy-side-effects-2339-4469/ 2022-11-12T01:55:27+00:00 https://de.pi-multilingual.rt.gw/section/pharmacotherapy-of-generalized-anxiety-disorder-2047-4043/ 2022-11-13T03:51:39+00:00 https://de.pi-multilingual.rt.gw/section/adhd-pharmacotherapy-starting-treatment-2045-4038/ 2022-11-13T16:29:26+00:00 https://de.pi-multilingual.rt.gw/section/adverse-effects-and-pharmacokinetics-2050-4048/ 2022-11-14T11:25:14+00:00 https://de.pi-multilingual.rt.gw/section/duloxetine-snri-used-in-pain-disorders-2340-4471/ 2022-11-14T13:01:47+00:00 https://de.pi-multilingual.rt.gw/section/stimulants-for-adhd-summary-of-formulations-2339-4470/ 2022-11-16T07:21:52+00:00 https://de.pi-multilingual.rt.gw/section/the-bipolar-disorder-concept-from-kraepelin-to-dsm-5-2335-4460/ 2022-11-17T03:34:48+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-induced-sexual-dysfunction-2343-4474/ 2022-11-18T15:01:37+00:00 https://de.pi-multilingual.rt.gw/section/side-effects-pharmacokinetics-and-prescribing-information-2044-4035/ 2022-11-21T18:24:26+00:00 https://de.pi-multilingual.rt.gw/section/mechanism-of-action-and-clinical-uses-2338-4464/ 2022-11-22T19:17:13+00:00 https://de.pi-multilingual.rt.gw/section/tricyclic-antidepressants-adverse-effects-and-pharmacokinetics-2344-4478/ 2022-11-23T20:17:03+00:00 https://de.pi-multilingual.rt.gw/section/adhd-pharmacotherapy-starting-treatment-2339-4468/ 2022-11-24T17:58:03+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-depression-pharmacotherapy-part-2-prescribing-antidepressants-2040-4029/ 2022-11-27T01:52:47+00:00 https://de.pi-multilingual.rt.gw/section/stimulants-for-adhd-summary-of-formulations-2045-4040/ 2022-11-27T02:57:12+00:00 https://de.pi-multilingual.rt.gw/section/carbamazepine-2334-4449/ 2022-11-27T09:57:51+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-depression-pharmacotherapy-part-1-2040-4028/ 2022-11-29T17:48:22+00:00 https://de.pi-multilingual.rt.gw/section/administration-of-st-johns-wort-and-valerian-in-children-and-adolescents-2677-5311/ 2022-11-29T20:51:17+00:00 https://de.pi-multilingual.rt.gw/section/an-introduction-to-parasomnias-2644-5340/ 2022-11-30T15:23:33+00:00 https://de.pi-multilingual.rt.gw/section/diagnosing-rem-sleep-behavior-disorder-2644-5341/ 2022-11-30T15:23:33+00:00 https://de.pi-multilingual.rt.gw/section/understanding-rbd-behaviors-2644-5342/ 2022-11-30T15:23:33+00:00 https://de.pi-multilingual.rt.gw/section/prevalence-assessment-and-management-of-rbd-2644-5343/ 2022-11-30T15:23:33+00:00 https://de.pi-multilingual.rt.gw/section/medication-induced-rbd-an-overview-with-a-focus-on-ssri-antidepressants-2644-5344/ 2022-11-30T15:23:33+00:00 https://de.pi-multilingual.rt.gw/section/medication-induced-rbd-other-antidepressant-classes-2644-5345/ 2022-11-30T15:23:33+00:00 https://de.pi-multilingual.rt.gw/section/restless-legs-syndrome-and-antiderpessants-2644-5346/ 2022-11-30T15:23:33+00:00 https://de.pi-multilingual.rt.gw/section/a-clinical-case-and-exclusive-videos-on-rbd-and-rls-2644-5347/ 2022-11-30T15:23:34+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2644-5348/ 2022-11-30T15:23:34+00:00 https://de.pi-multilingual.rt.gw/section/pharmacokinetic-drug-drug-interactions-antipsychotics-and-mood-stabilizers-2334-4459/ 2022-11-30T23:22:21+00:00 https://de.pi-multilingual.rt.gw/section/duloxetine-snri-used-in-pain-disorders-2046-4041/ 2022-12-01T16:24:44+00:00 https://de.pi-multilingual.rt.gw/section/second-generation-antipsychotics-2039-4017/ 2022-12-02T15:28:52+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-discontinuation-syndrome-2049-4045/ 2022-12-03T16:50:45+00:00 https://de.pi-multilingual.rt.gw/section/adult-adhd-diagnosis-and-clinical-features-2339-4466/ 2022-12-05T17:22:47+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-disorder-in-dsm-5-highlights-of-changes-from-dsm-iv-tr-to-dsm-5-2041-4031/ 2022-12-05T18:03:00+00:00 https://de.pi-multilingual.rt.gw/section/update-on-the-risk-of-fetal-malformations-2039-4021/ 2022-12-07T04:50:01+00:00 https://de.pi-multilingual.rt.gw/section/pharmacology-and-indications-2050-4047/ 2022-12-10T01:12:17+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-2039-4016/ 2022-12-11T12:43:43+00:00 https://de.pi-multilingual.rt.gw/section/drug-metabolism-the-importance-of-phase-i-and-ii-reactions-2039-4023/ 2022-12-12T10:32:57+00:00 https://de.pi-multilingual.rt.gw/section/treatment-non-adherence-its-importance-and-how-to-avoid-it-2040-4027/ 2022-12-13T04:22:21+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-disorder-in-dsm-5-highlights-of-changes-from-dsm-iv-tr-to-dsm-5-2335-4461/ 2022-12-13T14:56:37+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-2334-4450/ 2022-12-14T03:20:19+00:00 https://de.pi-multilingual.rt.gw/section/drug-metabolism-enzyme-induction-and-inhibition-2334-4458/ 2022-12-14T07:32:20+00:00 https://de.pi-multilingual.rt.gw/section/generalized-anxiety-disorder-diagnosis-and-clinical-features-2047-4042/ 2022-12-16T03:44:56+00:00 https://de.pi-multilingual.rt.gw/section/mirtazapine-the-essentials-2050-4049/ 2022-12-18T23:31:51+00:00 https://de.pi-multilingual.rt.gw/section/update-on-the-risk-of-pphn-2039-4022/ 2022-12-19T16:26:07+00:00 https://de.pi-multilingual.rt.gw/section/valproate-2334-4448/ 2022-12-20T22:36:11+00:00 https://de.pi-multilingual.rt.gw/section/adhd-drugs-introduction-and-mechanisms-of-action-2339-4467/ 2022-12-21T10:36:03+00:00 https://de.pi-multilingual.rt.gw/section/update-on-the-risk-of-fetal-malformations-2334-4455/ 2022-12-23T17:11:56+00:00 https://de.pi-multilingual.rt.gw/section/screening-instruments-2041-4033/ 2022-12-29T16:09:06+00:00 https://de.pi-multilingual.rt.gw/section/a-brief-review-of-nutritional-status-in-the-us-2689-5354/ 2022-12-30T19:41:42+00:00 https://de.pi-multilingual.rt.gw/section/dietary-patterns-and-mental-health-2689-5355/ 2022-12-30T19:41:42+00:00 https://de.pi-multilingual.rt.gw/section/depression-and-mediterranean-style-diet-2689-5356/ 2022-12-30T19:41:42+00:00 https://de.pi-multilingual.rt.gw/section/micronutrients-and-brain-functioning-2689-5357/ 2022-12-30T19:41:42+00:00 https://de.pi-multilingual.rt.gw/section/rationale-for-micronutrient-supplementation-in-mental-illness-2689-5358/ 2022-12-30T19:41:42+00:00 https://de.pi-multilingual.rt.gw/section/an-introduction-to-research-types-for-micronutrient-supplementation-2689-5359/ 2022-12-30T19:41:42+00:00 https://de.pi-multilingual.rt.gw/section/an-overview-of-standard-treatment-vs-cam-for-adhd-2689-5360/ 2022-12-30T19:41:43+00:00 https://de.pi-multilingual.rt.gw/section/evidence-of-bsms-for-pediatric-adhd-and-emotional-dysregulation-2689-5361/ 2022-12-30T19:41:43+00:00 https://de.pi-multilingual.rt.gw/section/evidence-of-bsms-for-adult-adhd-2689-5362/ 2022-12-30T19:41:43+00:00 https://de.pi-multilingual.rt.gw/section/evidence-of-bsms-for-diverse-psychiatric-diagnoses-2689-5363/ 2022-12-30T19:41:43+00:00 https://de.pi-multilingual.rt.gw/section/bsms-for-infractions-in-youth-2689-5364/ 2022-12-30T19:41:43+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2689-5365/ 2022-12-30T19:41:43+00:00 https://de.pi-multilingual.rt.gw/section/managing-clozapine-related-enuresis-2688-5335/ 2023-01-25T18:50:44+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-motor-hyperactivity-and-inattention-in-asd-stimulants-2695-5377/ 2023-02-01T00:41:07+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-motor-hyperactivity-and-inattention-in-asd-nonstimulants-2695-5378/ 2023-02-01T00:41:07+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-repetitive-behaviors-in-asd-antidepressants-2695-5379/ 2023-02-01T00:41:07+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-depression-and-anxiety-in-asd-antidepressants-and-other-strategies-2695-5380/ 2023-02-01T00:41:07+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-irritability-in-asd-other-antipsychotic-medications-and-parent-training-2695-5382/ 2023-02-01T00:41:07+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-irritability-in-asd-mood-stabilizers-and-other-strategies-2695-5383/ 2023-02-01T00:41:08+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-sleep-disturbances-in-asd-melatonin-and-other-strategies-2695-5384/ 2023-02-01T00:41:08+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-impaired-social-relatedness-in-asd-2695-5385/ 2023-02-01T00:41:08+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2695-5386/ 2023-02-01T00:41:08+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-irritability-in-asd-risperidone-and-aripiprazole-2695-5381/ 2023-02-01T01:11:52+00:00 https://de.pi-multilingual.rt.gw/section/mechanism-of-action-and-clinical-uses-2044-4034/ 2023-02-19T15:08:19+00:00 https://de.pi-multilingual.rt.gw/section/quetiapine-in-the-anxiety-dimension-of-mood-disorders-2621-5136/ 2023-02-20T18:26:24+00:00 https://de.pi-multilingual.rt.gw/section/ketamine-for-adolescent-depression-2747-5405/ 2023-02-28T20:29:57+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-induced-hyperprolactinemia-in-youth-2747-5406/ 2023-02-28T20:35:00+00:00 https://de.pi-multilingual.rt.gw/section/a-background-on-parasomnias-2698-5407/ 2023-02-28T22:58:08+00:00 https://de.pi-multilingual.rt.gw/section/diagnosing-sleep-related-eating-disorder-sred-2698-5408/ 2023-02-28T22:58:08+00:00 https://de.pi-multilingual.rt.gw/section/medication-induced-sred-sleepwalking-and-sleepdriving-2698-5409/ 2023-02-28T22:58:08+00:00 https://de.pi-multilingual.rt.gw/section/zolpidem-induced-sleepwalking-and-sred-2698-5411/ 2023-02-28T22:58:09+00:00 https://de.pi-multilingual.rt.gw/section/risk-predictors-for-hypnosedative-related-complex-sleep-behaviors-2698-5412/ 2023-02-28T22:58:09+00:00 https://de.pi-multilingual.rt.gw/section/parasomnias-among-psychiatric-outpatients-findings-on-sred-2698-5413/ 2023-02-28T22:58:09+00:00 https://de.pi-multilingual.rt.gw/section/clinical-cases-and-videos-2698-5414/ 2023-02-28T22:58:09+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2698-5415/ 2023-02-28T23:26:27+00:00 https://de.pi-multilingual.rt.gw/section/updates-on-treatments-for-adolescent-anorexia-nervosa-2502-4896/ 2023-03-08T17:59:10+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-safety-of-transcranial-direct-current-stimulation-for-treating-negative-symptoms-in-schizophrenia-2502-4898/ 2023-03-08T17:59:10+00:00 https://de.pi-multilingual.rt.gw/section/transcranial-magnetic-stimulation-for-positive-symptoms-in-schizophrenia-a-systematic-review-2502-4899/ 2023-03-08T17:59:10+00:00 https://de.pi-multilingual.rt.gw/section/omega-3-and-polyunsaturated-fat-for-prevention-of-depression-and-anxiety-symptoms-meta-analyses-of-randomized-trials-2512-4902/ 2023-03-08T18:01:55+00:00 https://de.pi-multilingual.rt.gw/section/long-acting-injections-in-schizophrenia-a-3-year-update-on-randomized-controlled-trials-published-january-2016march-2019-2512-4903/ 2023-03-08T18:01:55+00:00 https://de.pi-multilingual.rt.gw/section/effects-of-hormonal-contraceptives-on-mood-a-focus-on-emotion-recognition-and-reactivity-reward-processing-and-stress-response-2512-4904/ 2023-03-08T18:01:55+00:00 https://de.pi-multilingual.rt.gw/section/evidence-for-stress-like-alterations-in-the-hpa-axis-in-women-taking-oral-contraceptives-2517-4913/ 2023-03-08T18:04:49+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-safety-of-lumateperone-for-treatment-of-schizophrenia-2517-4915/ 2023-03-08T18:04:49+00:00 https://de.pi-multilingual.rt.gw/section/a-network-meta-analysis-of-the-effects-of-psychotherapies-pharmacotherapies-and-their-combination-in-the-treatment-of-adult-depression-2517-4917/ 2023-03-08T18:04:49+00:00 https://de.pi-multilingual.rt.gw/section/a-systematic-review-of-neurologic-symptoms-and-complications-of-covid-19-2519-4928/ 2023-03-08T18:06:18+00:00 https://de.pi-multilingual.rt.gw/section/double-blind-randomized-controlled-study-of-the-efficacy-safety-and-tolerability-of-eszopiclone-vs-placebo-for-the-treatment-of-patients-with-posttraumatic-stress-disorder-and-insomnia-2549-4968/ 2023-03-08T18:10:37+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-long-acting-injectable-antipsychotics-vs-usual-care-on-time-to-first-hospitalization-in-early-phase-schizophrenia-a-randomized-clinical-trial-2549-4970/ 2023-03-08T18:10:37+00:00 https://de.pi-multilingual.rt.gw/section/the-risk-of-relapse-of-depression-during-pregnancy-after-discontinuation-of-antidepressants-a-systematic-review-and-meta-analysis-2627-4977/ 2023-03-09T16:53:20+00:00 https://de.pi-multilingual.rt.gw/section/electroconvulsive-therapy-in-mania-a-review-of-80-years-of-clinical-experience-2573-4988/ 2023-03-09T16:55:57+00:00 https://de.pi-multilingual.rt.gw/section/psychological-interventions-as-an-alternative-and-add-on-to-antidepressant-medication-to-prevent-depressive-relapse-systematic-review-and-meta-analysis-2573-4990/ 2023-03-09T16:55:57+00:00 https://de.pi-multilingual.rt.gw/section/new-somatic-treatments-for-child-and-adolescent-depression-part-1-2578-5017/ 2023-03-09T16:58:23+00:00 https://de.pi-multilingual.rt.gw/section/drug-induced-hyperthermic-syndromes-in-psychiatry-2591-5045/ 2023-03-09T17:05:40+00:00 https://de.pi-multilingual.rt.gw/section/neuropsychiatric-symptoms-associated-with-cerebral-small-vessel-disease-a-systematic-review-and-meta-analysis-2591-5047/ 2023-03-09T17:05:40+00:00 https://de.pi-multilingual.rt.gw/section/new-approaches-to-symptomatic-treatments-for-alzheimers-disease-2591-5048/ 2023-03-09T17:05:40+00:00 https://de.pi-multilingual.rt.gw/section/risk-of-suicide-among-patients-with-parkinson-disease-2591-5049/ 2023-03-09T17:05:41+00:00 https://de.pi-multilingual.rt.gw/section/single-vs-multiple-daily-dosing-regimens-of-psychotropic-drugs-for-psychiatric-disorders-a-systematic-review-and-meta-analysis-2596-5052/ 2023-03-09T17:06:52+00:00 https://de.pi-multilingual.rt.gw/section/utility-of-oxcarbazepine-in-the-treatment-of-childhood-and-adolescent-psychiatric-symptoms-2596-5053/ 2023-03-13T18:58:12+00:00 https://de.pi-multilingual.rt.gw/section/increased-prevalence-of-subclinical-hypothyroidism-and-thyroid-autoimmunity-in-depressed-adolescents-results-from-a-clinical-cross-sectional-study-in-comparison-to-the-general-pediatric-population-259/ 2023-03-13T18:58:12+00:00 https://de.pi-multilingual.rt.gw/section/trial-of-psilocybin-vs-escitalopram-for-depression-2603-5066/ 2023-03-13T19:02:54+00:00 https://de.pi-multilingual.rt.gw/section/frailty-as-a-predictor-of-mortality-in-late-life-depression-a-prospective-clinical-cohort-study-2603-5068/ 2023-03-13T19:02:55+00:00 https://de.pi-multilingual.rt.gw/section/posttraumatic-stress-disorder-symptomatology-and-substance-use-in-an-outpatient-concurrent-disorders-sample-2603-5067/ 2023-03-13T19:02:55+00:00 https://de.pi-multilingual.rt.gw/section/adverse-childhood-experiences-and-maternal-anxiety-and-depression-a-meta-analysis-2604-5080/ 2023-03-13T19:28:01+00:00 https://de.pi-multilingual.rt.gw/section/fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19-2604-5082/ 2023-03-13T19:28:01+00:00 https://de.pi-multilingual.rt.gw/section/fluoxetine-for-stroke-a-mixed-bag-of-outcomes-2617-5120/ 2023-03-13T19:38:45+00:00 https://de.pi-multilingual.rt.gw/section/2-adrenergic-agonists-or-stimulants-for-preschool-age-children-with-attention-deficithyperactivity-disorder-2617-5121/ 2023-03-13T19:38:45+00:00 https://de.pi-multilingual.rt.gw/section/suicidality-and-self-injury-with-selective-serotonin-reuptake-inhibitors-in-youth-occurrence-predictors-and-timing-2617-5122/ 2023-03-13T19:38:46+00:00 https://de.pi-multilingual.rt.gw/section/the-psychotropic-effect-of-vitamin-d-supplementation-on-schizophrenia-symptoms-2621-5135/ 2023-03-13T19:45:50+00:00 https://de.pi-multilingual.rt.gw/section/variable-patterns-of-remission-from-adhd-in-the-multi-modal-treatment-study-of-adhd-2621-5137/ 2023-03-13T19:45:50+00:00 https://de.pi-multilingual.rt.gw/section/prospects-for-new-drugs-to-treat-binge-eating-disorder-insights-from-psychopathology-and-neuropharmacology-2621-5138/ 2023-03-13T19:45:50+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-active-vs-sham-intermittent-theta-burst-transcranial-magnetic-stimulation-for-patients-with-bipolar-depression-a-randomized-clinical-trial-2631-5149/ 2023-03-13T19:50:31+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-tolerability-of-atypical-antipsychotics-for-acute-bipolar-depression-a-network-meta-analysis-2631-5151/ 2023-03-13T19:50:32+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-zuranolone-vs-placebo-in-postpartum-depression-2632-5166/ 2023-03-13T20:01:54+00:00 https://de.pi-multilingual.rt.gw/section/repetitive-transcranial-magnetic-stimulation-for-smoking-cessation-a-pivotal-multicenter-doubleblind-randomized-controlled-trial-2640-5186/ 2023-03-13T20:10:07+00:00 https://de.pi-multilingual.rt.gw/section/treatment-induced-mood-switching-in-affective-disorders-2640-5189/ 2023-03-13T20:10:07+00:00 https://de.pi-multilingual.rt.gw/section/effects-of-caffeine-on-anxiety-and-panic-attacks-in-patients-with-panic-disorder-a-systematic-review-and-meta-analysis-2645-5204/ 2023-03-13T20:11:54+00:00 https://de.pi-multilingual.rt.gw/section/rapid-tranquilization-of-the-agitated-patient-in-the-emergency-department-a-systematic-review-and-network-meta-analysis-2657-5228/ 2023-03-13T20:19:00+00:00 https://de.pi-multilingual.rt.gw/section/a-mini-review-of-pharmacologic-and-psychosocial-interventions-for-reducing-irritability-among-youth-with-adhd-2657-5229/ 2023-03-13T20:19:00+00:00 https://de.pi-multilingual.rt.gw/section/guidelines-for-the-management-of-psychosis-in-the-context-of-mood-disorders-2658-5234/ 2023-03-14T16:53:42+00:00 https://de.pi-multilingual.rt.gw/section/the-efficacy-of-psychotherapies-and-pharmacotherapies-for-mental-disorders-in-adults-an-umbrella-review-and-meta-analytic-evaluation-of-recent-meta-analyses-2670-5263/ 2023-03-14T17:00:45+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-safety-of-supraphysiologic-doses-of-levothyroxine-for-patients-with-bipolar-depression-in-adults-a-systematic-review-2670-5265/ 2023-03-14T17:00:45+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-safety-and-tolerability-of-ziprasidone-in-youth-2747-5404/ 2023-03-17T02:42:28+00:00 https://de.pi-multilingual.rt.gw/section/screening-instruments-2335-4463/ 2023-03-22T11:47:35+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2700-5428/ 2023-03-23T19:32:50+00:00 https://de.pi-multilingual.rt.gw/section/overview-of-autism-spectrum-disorder-2695-5376/ 2023-03-28T17:23:56+00:00 https://de.pi-multilingual.rt.gw/section/balovaptan-for-social-communication-in-youth-with-asd-2748-5434/ 2023-03-31T17:23:52+00:00 https://de.pi-multilingual.rt.gw/section/risk-of-cardiovascular-diseases-associated-with-medications-used-in-adhd-2748-5435/ 2023-03-31T17:32:46+00:00 https://de.pi-multilingual.rt.gw/section/relative-age-and-psychotropic-drug-use-in-preterm-and-term-born-children-2748-5436/ 2023-03-31T17:38:15+00:00 https://de.pi-multilingual.rt.gw/section/disparities-in-pharmacologic-restraint-use-in-pediatric-emergency-departments-2748-5438/ 2023-03-31T18:00:09+00:00 https://de.pi-multilingual.rt.gw/section/a-clinical-case-dsm-5-criteria-epidemiology-and-course-of-tic-disorders-2700-5416/ 2023-03-31T18:56:25+00:00 https://de.pi-multilingual.rt.gw/section/understanding-tic-disorders-2700-5417/ 2023-03-31T18:56:25+00:00 https://de.pi-multilingual.rt.gw/section/assessing-and-screening-for-tic-symptoms-2700-5418/ 2023-03-31T18:56:25+00:00 https://de.pi-multilingual.rt.gw/section/differential-diagnosis-for-tic-disorders-2700-5419/ 2023-03-31T18:56:25+00:00 https://de.pi-multilingual.rt.gw/section/tic-disorders-and-psychiatric-comorbidities-2700-5420/ 2023-03-31T18:56:25+00:00 https://de.pi-multilingual.rt.gw/section/overview-of-treatment-for-tic-disorders-2700-5421/ 2023-03-31T18:56:26+00:00 https://de.pi-multilingual.rt.gw/section/primary-pharmacologic-treatments-for-tics-2700-5422/ 2023-03-31T18:56:26+00:00 https://de.pi-multilingual.rt.gw/section/secondary-pharmacologic-treatments-2700-5423/ 2023-03-31T18:56:26+00:00 https://de.pi-multilingual.rt.gw/section/tertiary-pharmacologic-treatment-for-tics-2700-5424/ 2023-03-31T18:56:26+00:00 https://de.pi-multilingual.rt.gw/section/treatment-optimization-for-tic-disorders-2700-5425/ 2023-03-31T18:56:26+00:00 https://de.pi-multilingual.rt.gw/section/alternative-and-experimental-treatments-for-tic-disorders-2700-5426/ 2023-03-31T18:56:26+00:00 https://de.pi-multilingual.rt.gw/section/solving-the-clinical-case-and-tips-for-clinicians-treating-tic-disorders-2700-5427/ 2023-03-31T18:56:26+00:00 https://de.pi-multilingual.rt.gw/section/reported-side-effects-associated-with-medication-nonadherence-among-youth-with-adhd-2749-5455/ 2023-04-26T19:03:42+00:00 https://de.pi-multilingual.rt.gw/section/trends-in-antipsychotic-prescribing-in-youth-2749-5458/ 2023-04-26T19:16:31+00:00 https://de.pi-multilingual.rt.gw/section/psychopharmacologic-treatment-algorithms-for-bipolar-disorder-in-youth-2749-5457/ 2023-04-26T19:24:27+00:00 https://de.pi-multilingual.rt.gw/section/cost-effectiveness-of-treatments-for-adhd-and-asd-in-youth-2749-5459/ 2023-04-26T19:24:27+00:00 https://de.pi-multilingual.rt.gw/section/zolpidem-and-amnestic-complex-behaviors-during-sleep-2698-5410/ 2023-04-28T02:55:19+00:00 https://de.pi-multilingual.rt.gw/section/understanding-the-psychological-response-to-cancer-2724-5439/ 2023-04-28T20:42:42+00:00 https://de.pi-multilingual.rt.gw/section/making-the-right-diagnosis-depression-vs-grief-and-demoralization-2724-5441/ 2023-04-28T20:42:42+00:00 https://de.pi-multilingual.rt.gw/section/treating-depressive-disorders-in-patients-with-cancer-2724-5442/ 2023-04-28T20:42:43+00:00 https://de.pi-multilingual.rt.gw/section/anxiety-disorders-in-patients-with-cancer-2724-5443/ 2023-04-28T20:42:43+00:00 https://de.pi-multilingual.rt.gw/section/delirium-a-neuropsychiatric-complication-in-patients-with-cancer-2724-5445/ 2023-04-28T20:42:43+00:00 https://de.pi-multilingual.rt.gw/section/delirium-in-patients-with-cancer-diagnosis-and-implications-2724-5446/ 2023-04-28T20:42:43+00:00 https://de.pi-multilingual.rt.gw/section/assessment-of-delirium-in-patients-with-cancer-2724-5447/ 2023-04-28T20:42:43+00:00 https://de.pi-multilingual.rt.gw/section/management-of-delirium-in-patients-with-cancer-2724-5448/ 2023-04-28T20:42:43+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2724-5449/ 2023-04-28T20:42:43+00:00 https://de.pi-multilingual.rt.gw/section/treating-anxiety-disorders-in-patients-with-cancer-2724-5444/ 2023-04-29T22:55:04+00:00 https://de.pi-multilingual.rt.gw/section/safety-and-tolerability-of-cariprazine-in-pediatric-patients-2750-5474/ 2023-05-30T19:05:14+00:00 https://de.pi-multilingual.rt.gw/section/melatonin-use-and-the-risk-of-self-harm-and-unintentional-injuries-in-youth-2750-5472/ 2023-05-30T19:18:48+00:00 https://de.pi-multilingual.rt.gw/section/racial-disparities-in-pediatric-psychotropic-prescriptions-2750-5473/ 2023-05-30T19:18:48+00:00 https://de.pi-multilingual.rt.gw/section/growth-trajectories-in-stimulant-treated-children-ages-612-2750-5475/ 2023-05-30T19:18:49+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-tolerability-of-antipsychotics-for-juvenile-psychotic-disorders-2750-5476/ 2023-05-30T19:31:13+00:00 https://de.pi-multilingual.rt.gw/section/update-on-the-risk-of-pphn-2334-4456/ 2023-06-01T14:12:01+00:00 https://de.pi-multilingual.rt.gw/section/depressive-disorders-and-risk-of-suicide-in-patients-with-cancer-2724-5440/ 2023-06-20T15:03:42+00:00 https://de.pi-multilingual.rt.gw/section/n-acetylcysteine-in-adolescent-alcohol-use-disorder-2751-5492/ 2023-06-27T19:02:28+00:00 https://de.pi-multilingual.rt.gw/section/effectiveness-of-amphetamine-suspension-in-adhd-day-long-efficacy-2751-5496/ 2023-06-28T01:55:19+00:00 https://de.pi-multilingual.rt.gw/section/pediatric-pharmacogenomic-profiling-in-the-emergency-department-2751-5497/ 2023-06-28T02:02:51+00:00 https://de.pi-multilingual.rt.gw/section/prescribing-stimulants-for-youth-with-adhd-and-co-occurring-cannabis-use-2751-5495/ 2023-06-28T19:20:38+00:00 https://de.pi-multilingual.rt.gw/section/metformin-for-weight-gain-in-youth-on-atypical-antipsychotics-2751-5494/ 2023-06-30T22:36:03+00:00 https://de.pi-multilingual.rt.gw/section/managing-adverse-effects-of-antidepressants-in-youth-2752-5508/ 2023-07-24T20:44:22+00:00 https://de.pi-multilingual.rt.gw/section/ages-impact-on-antidepressant-response-2752-5509/ 2023-07-24T20:59:47+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigines-efficacy-and-safety-in-pediatric-mood-disorders-2752-5510/ 2023-07-24T21:07:30+00:00 https://de.pi-multilingual.rt.gw/section/managing-adhd-and-anxiety-in-children-a-clinical-guide-2752-5511/ 2023-07-24T21:15:22+00:00 https://de.pi-multilingual.rt.gw/section/dose-titration-of-oros-methylphenidate-in-pediatric-adhd-2752-5512/ 2023-07-24T21:22:17+00:00 https://de.pi-multilingual.rt.gw/section/st-johns-wort-and-valerian-potential-indications-in-children-and-adolescents-2677-5310/ 2023-07-25T00:19:45+00:00 https://de.pi-multilingual.rt.gw/section/administration-of-n-acetylcysteine-and-s-adenosylmethionine-in-children-and-adolescents-2677-5313/ 2023-07-25T00:19:45+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-serotonin-5-ht-in-impulsivity-aggression-anxiety-stress-and-cognition-2064-4160/ 2023-07-26T18:55:51+00:00 https://de.pi-multilingual.rt.gw/section/bsms-ingredients-and-doses-2729-5514/ 2023-08-01T13:33:16+00:00 https://de.pi-multilingual.rt.gw/section/bsms-safety-and-tolerability-2729-5515/ 2023-08-01T13:33:16+00:00 https://de.pi-multilingual.rt.gw/section/bsms-and-potentiation-of-psychotropic-medications-2729-5516/ 2023-08-01T13:33:17+00:00 https://de.pi-multilingual.rt.gw/section/strict-and-relative-contraindications-for-using-bsms-2729-5517/ 2023-08-01T13:33:17+00:00 https://de.pi-multilingual.rt.gw/section/bsms-and-drug-interactions-2729-5518/ 2023-08-01T13:33:17+00:00 https://de.pi-multilingual.rt.gw/section/practical-tips-for-using-bsms-in-the-clinical-practice-2729-5519/ 2023-08-01T13:33:17+00:00 https://de.pi-multilingual.rt.gw/section/dosing-empowerplus-advanced-and-daily-essential-nutrients-2729-5520/ 2023-08-01T13:33:17+00:00 https://de.pi-multilingual.rt.gw/section/starting-bsms-in-your-clinical-practice-a-step-wise-process-2729-5521/ 2023-08-01T13:33:17+00:00 https://de.pi-multilingual.rt.gw/section/other-considerations-when-using-bsms-2729-5522/ 2023-08-01T13:33:18+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2729-5524/ 2023-08-01T13:33:18+00:00 https://de.pi-multilingual.rt.gw/section/an-introduction-to-using-bsm-in-the-clinical-practice-2729-5513/ 2023-08-01T17:38:14+00:00 https://de.pi-multilingual.rt.gw/section/clinical-cases-2729-5523/ 2023-08-15T15:55:05+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2766-5536/ 2023-08-16T19:12:05+00:00 https://de.pi-multilingual.rt.gw/section/psychosocial-functioning-in-transgender-youth-after-2-years-of-hormones-2753-5537/ 2023-08-21T21:23:25+00:00 https://de.pi-multilingual.rt.gw/section/personalizing-atomoxetine-dosing-in-children-with-adhd-2753-5539/ 2023-08-21T21:32:45+00:00 https://de.pi-multilingual.rt.gw/section/safety-and-tolerability-of-serdexmethylphenidatedexmethylphenidate-in-children-with-adhd-2753-5540/ 2023-08-21T21:37:41+00:00 https://de.pi-multilingual.rt.gw/section/qtc-prolongation-and-escitalopram-a-safer-antidepressant-2351-4534/ 2023-08-28T01:01:17+00:00 https://de.pi-multilingual.rt.gw/section/qtc-prolongation-with-citalopram-evidence-and-controversy-2351-4533/ 2023-08-28T01:02:27+00:00 https://de.pi-multilingual.rt.gw/section/citalopram-for-acute-and-preventive-efficacy-in-bipolar-depression-cape-bd-a-randomized-double-blind-placebo-controlled-trial-2580-5033/ 2023-08-28T21:45:40+00:00 https://de.pi-multilingual.rt.gw/section/when-and-how-to-treat-agitation-in-alzheimers-disease-dementia-with-citalopram-and-escitalopram-2563-4821/ 2023-08-28T21:51:00+00:00 https://de.pi-multilingual.rt.gw/section/how-should-i-use-antidepressants-in-patients-at-risk-for-qtc-prolongation-2351-4536/ 2023-08-28T22:06:37+00:00 https://de.pi-multilingual.rt.gw/section/in-search-of-a-dose-response-relationship-in-ssrisa-systematic-review-meta-analysis-and-network-meta-analysis-2573-4992/ 2023-08-28T22:08:41+00:00 https://de.pi-multilingual.rt.gw/section/association-between-fiasma-psychotropic-medications-and-reduced-risk-of-intubation-or-death-in-individuals-with-psychiatric-disorders-hospitalized-for-severe-covid-19-an-observational-multicenter-stud/ 2023-08-28T22:10:27+00:00 https://de.pi-multilingual.rt.gw/section/a-randomized-double-blind-placebo-controlled-trial-of-combined-escitalopram-and-memantine-for-older-adults-with-major-depression-and-subjective-memory-complaints-2502-4897/ 2023-08-28T22:26:35+00:00 https://de.pi-multilingual.rt.gw/section/s-adenosylmethionine-same-for-depression-what-does-the-evidence-say-2066-4181/ 2023-08-28T22:28:45+00:00 https://de.pi-multilingual.rt.gw/section/major-depressive-disorder-algorithm-was-the-antidepressant-trial-adequate-node-4-2534-4770/ 2023-08-28T22:29:41+00:00 https://de.pi-multilingual.rt.gw/section/procognitive-effects-of-antidepressants-and-other-therapeutic-agents-in-major-depressive-disorder-a-systematic-review-2627-4975/ 2023-08-28T22:30:45+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-psychosis-and-schizophrenia-in-children-and-adolescents-antipsychotic-dosing-monitoring-and-side-effects-2654-5209/ 2023-08-29T12:58:09+00:00 https://de.pi-multilingual.rt.gw/section/second-generation-antipsychotics-and-other-augmentation-agents-in-treatment-resistant-ocd-2523-4891/ 2023-08-29T12:59:16+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-drug-use-and-pneumonia-systematic-review-and-meta-analysis-2529-4758/ 2023-08-29T13:01:02+00:00 https://de.pi-multilingual.rt.gw/section/comparison-of-the-metabolic-characteristics-of-newer-second-generation-antipsychotics-2604-5083/ 2023-08-29T13:02:22+00:00 https://de.pi-multilingual.rt.gw/section/types-of-antipsychotic-switching-between-po-agents-and-from-po-to-lai-2642-5175/ 2023-08-29T13:03:15+00:00 https://de.pi-multilingual.rt.gw/section/chlorpromazine-as-a-potential-antipsychotic-choice-in-covid-19-treatment-2580-5030/ 2023-08-29T13:07:30+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-quetiapine-for-delirium-prevention-in-hospitalized-older-medical-patients-a-randomized-double-blind-controlled-trial-2604-5081/ 2023-08-29T13:14:05+00:00 https://de.pi-multilingual.rt.gw/section/management-of-mania-with-mixed-features-nodes-2a-2b-and-2c-2490-4691/ 2023-08-29T13:23:28+00:00 https://de.pi-multilingual.rt.gw/section/pharmacotherapy-for-borderline-personality-disorder-an-update-of-published-unpublished-and-ongoing-studies-2549-4967/ 2023-08-29T13:28:18+00:00 https://de.pi-multilingual.rt.gw/section/risk-of-major-malformations-following-first-trimester-exposure-to-olanzapine-2753-5538/ 2023-08-29T17:01:15+00:00 https://de.pi-multilingual.rt.gw/section/use-of-lithium-in-pediatric-bipolar-disorders-and-externalizing-childhood-related-disorders-2753-5541/ 2023-08-29T17:01:16+00:00 https://de.pi-multilingual.rt.gw/section/patient-and-clinical-factors-associated-with-response-to-medications-for-posttraumatic-stress-disorder-2657-5227/ 2023-08-29T19:22:51+00:00 https://de.pi-multilingual.rt.gw/section/postmarketing-safety-concerns-with-esketamine-a-disproportionality-analysis-of-spontaneous-reports-submitted-to-the-fda-adverse-event-reporting-system-2591-5046/ 2023-08-29T19:24:56+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-switching-after-the-first-failed-trial-in-major-depressive-disorder-node-4b-part-1-2534-4771/ 2023-08-29T19:34:49+00:00 https://de.pi-multilingual.rt.gw/section/alternatives-to-an-ssri-as-the-first-line-choice-node-3a-2063-4148/ 2023-08-29T19:39:13+00:00 https://de.pi-multilingual.rt.gw/section/additional-clinical-tips-for-treating-schizophrenia-in-children-and-adolescents-2654-5212/ 2023-08-29T20:01:46+00:00 https://de.pi-multilingual.rt.gw/section/gad-pharmacotherapy-augmenting-vs-switching-in-partial-responders-2063-4154/ 2023-08-29T20:02:41+00:00 https://de.pi-multilingual.rt.gw/section/in-the-aftermath-of-clozapine-discontinuation-comparative-effectiveness-and-safety-of-antipsychotics-in-patients-with-schizophrenia-who-discontinue-clozapine-2517-4914/ 2023-08-29T20:03:33+00:00 https://de.pi-multilingual.rt.gw/section/adverse-drug-reactions-associated-with-drugs-prescribed-in-psychiatry-a-retrospective-descriptive-analysis-in-a-tertiary-care-hospital-2640-5185/ 2023-08-29T20:10:14+00:00 https://de.pi-multilingual.rt.gw/section/study-of-mirtazapine-for-agitated-behaviors-in-dementia-symbad-a-randomised-double-blind-placebo-controlled-trial-2645-5200/ 2023-08-29T20:12:54+00:00 https://de.pi-multilingual.rt.gw/section/switching-to-imipramine-versus-add-on-mirtazapine-in-venlafaxine-resistant-major-depression-a-10-week-randomized-open-study-2570-4838/ 2023-08-29T21:24:10+00:00 https://de.pi-multilingual.rt.gw/section/nonurgent-inpatients-with-melancholic-depression-antidepressants-and-augmentation-with-lithium-t3-or-citalopram-node-3b-and-3c-2534-4769/ 2023-08-29T21:27:07+00:00 https://de.pi-multilingual.rt.gw/section/combining-antidepressants-vs-antidepressant-monotherapy-for-treatment-of-patients-with-acute-depression-2657-5230/ 2023-08-29T21:28:49+00:00 https://de.pi-multilingual.rt.gw/section/food-avoidance-diagnosis-and-treatment-of-avoidantrestrictive-food-intake-disorder-arfid-2538-4994/ 2023-08-29T21:29:25+00:00 https://de.pi-multilingual.rt.gw/section/management-of-bipolar-disorder-in-pregnancy-treatment-dilemmas-2766-5525/ 2023-08-29T23:17:40+00:00 https://de.pi-multilingual.rt.gw/section/impact-of-discontinuing-mood-stabilizers-in-pregnancy-2766-5526/ 2023-08-29T23:17:40+00:00 https://de.pi-multilingual.rt.gw/section/risks-of-using-lithium-in-pregnancy-2766-5527/ 2023-08-29T23:17:40+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-disorder-during-pregnancy-management-of-lithium-2766-5528/ 2023-08-29T23:17:40+00:00 https://de.pi-multilingual.rt.gw/section/risks-of-using-valproate-in-pregnancy-2766-5529/ 2023-08-29T23:17:41+00:00 https://de.pi-multilingual.rt.gw/section/risks-of-using-carbamazepine-and-lamotrigine-in-pregnancy-2766-5530/ 2023-08-29T23:17:41+00:00 https://de.pi-multilingual.rt.gw/section/effects-on-cognitive-function-and-neural-tube-defects-associated-with-fetal-exposure-to-aeds-2766-5531/ 2023-08-29T23:17:41+00:00 https://de.pi-multilingual.rt.gw/section/risks-of-using-antipsychotics-during-pregnancy-2766-5532/ 2023-08-29T23:17:41+00:00 https://de.pi-multilingual.rt.gw/section/risks-of-using-gabapentin-and-topiramate-in-pregnancy-2766-5533/ 2023-08-29T23:17:41+00:00 https://de.pi-multilingual.rt.gw/section/guiding-principles-for-treating-bipolar-disorder-during-pregnancy-2766-5534/ 2023-08-29T23:17:41+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignette-a-woman-with-bipolar-disorder-who-wishes-to-become-pregnant-2766-5535/ 2023-08-29T23:17:41+00:00 https://de.pi-multilingual.rt.gw/section/lithium-treatment-in-the-prevention-of-repeat-suicide-related-outcomes-in-veterans-with-major-depression-or-bipolar-disorder-2635-5182/ 2023-08-30T14:58:10+00:00 https://de.pi-multilingual.rt.gw/section/classic-mania-without-mixed-features-what-if-response-to-lithium-is-unsatisfactory-node-3-2490-4693/ 2023-08-30T14:59:03+00:00 https://de.pi-multilingual.rt.gw/section/management-of-mania-without-mixed-features-the-role-of-lithium-node-2d-2490-4692/ 2023-08-30T15:05:34+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-interactions-practical-recommendations-on-divalproex-carbamazepine-and-oral-contraceptives-use-2059-4120/ 2023-08-30T15:20:11+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-is-not-slow-comments-about-its-efficacy-in-bipolar-depression-2059-4119/ 2023-08-30T15:21:00+00:00 https://de.pi-multilingual.rt.gw/section/prescribing-antiepileptic-drugs-for-bipolar-disorder-during-pregnancy-valproate-carbamazepine-and-lamotrigine-2559-4950/ 2023-08-30T15:23:49+00:00 https://de.pi-multilingual.rt.gw/section/the-potential-use-of-folate-and-its-derivatives-in-treating-psychiatric-disorders-a-systematic-review-2670-5262/ 2023-08-30T15:29:54+00:00 https://de.pi-multilingual.rt.gw/section/treatment-options-in-older-age-bipolar-depression-lurasidone-and-lamotrigine-2526-4753/ 2023-08-30T15:31:10+00:00 https://de.pi-multilingual.rt.gw/section/evaluating-the-efficacy-and-safety-of-antidepressants-in-patients-with-bipolar-disorder-2502-4895/ 2023-08-30T15:31:49+00:00 https://de.pi-multilingual.rt.gw/section/treatment-implications-of-sleeprelated-problems-in-pediatric-anxiety-disorders-a-narrative-review-of-the-literature-2635-5181/ 2023-08-30T15:48:35+00:00 https://de.pi-multilingual.rt.gw/section/akathisia-and-atypical-antipsychotics-relation-to-suicidality-agitation-and-depression-in-a-clinical-trial-2657-5231/ 2023-08-30T18:52:48+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-pharmacologic-interventions-for-irritability-and-emotional-dysregulation-in-asd-2749-5456/ 2023-08-30T21:47:02+00:00 https://de.pi-multilingual.rt.gw/section/updates-in-psychopharmacology-for-the-core-and-associated-symptoms-of-asd-2747-5402/ 2023-08-30T21:50:48+00:00 https://de.pi-multilingual.rt.gw/section/effects-on-suicidal-risk-comparison-of-clozapine-to-other-newer-medicines-indicated-to-treat-schizophrenia-or-bipolar-disorder-2621-5134/ 2023-08-30T21:52:30+00:00 https://de.pi-multilingual.rt.gw/section/pharmacotherapy-of-autism-spectrum-disorder-results-from-the-randomized-baart-clinical-trial-2563-4824/ 2023-08-30T21:53:13+00:00 https://de.pi-multilingual.rt.gw/section/comparative-effects-of-18-antipsychotics-on-metabolic-function-in-patients-with-schizophrenia-predictors-of-metabolic-dysregulation-and-association-with-psychopathology-a-systematic-review-and-netw-25/ 2023-08-30T21:55:38+00:00 https://de.pi-multilingual.rt.gw/section/the-effects-of-antipsychotic-treatment-on-the-brain-of-patients-with-first-episode-schizophrenia-a-selective-review-of-longitudinal-mri-studies-2631-5150/ 2023-08-30T22:10:19+00:00 https://de.pi-multilingual.rt.gw/section/types-of-antipsychotic-switching-lai-to-po-and-lai-to-lai-2642-5176/ 2023-08-30T22:11:02+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-tolerability-and-acceptance-of-long-lasting-antipsychotics-in-youth-2748-5437/ 2023-08-30T22:14:13+00:00 https://de.pi-multilingual.rt.gw/section/relapse-prevention-strategies-for-depression-and-anxiety-in-remitted-youth-2779-5547/ 2023-09-19T00:09:41+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotics-in-the-treatment-of-youth-with-anorexia-nervosa-2779-5548/ 2023-09-19T00:14:27+00:00 https://de.pi-multilingual.rt.gw/section/effects-of-long-term-sertraline-use-on-pediatric-growth-and-development-2779-5549/ 2023-09-19T00:20:30+00:00 https://de.pi-multilingual.rt.gw/section/dissociative-effects-and-response-to-ketamine-in-youth-with-treatment-resistant-depression-2779-5551/ 2023-09-19T00:26:14+00:00 https://de.pi-multilingual.rt.gw/section/long-acting-injectable-antipsychotics-for-schizophrenia-spectrum-disorders-in-youth-2779-5552/ 2023-09-19T15:18:55+00:00 https://de.pi-multilingual.rt.gw/section/prescribing-in-the-era-of-biomedical-psychiatry-an-introduction-2767-5553/ 2023-09-26T18:56:28+00:00 https://de.pi-multilingual.rt.gw/section/understanding-the-problem-of-treatment-resistance-2767-5554/ 2023-09-26T18:56:28+00:00 https://de.pi-multilingual.rt.gw/section/taking-an-integrative-perspective-2767-5555/ 2023-09-26T18:56:28+00:00 https://de.pi-multilingual.rt.gw/section/basic-psychodynamic-concepts-2767-5556/ 2023-09-26T18:56:29+00:00 https://de.pi-multilingual.rt.gw/section/an-introduction-to-psychodynamic-psychopharmacology-2767-5557/ 2023-09-26T18:56:29+00:00 https://de.pi-multilingual.rt.gw/section/avoiding-mindbody-split-sources-of-dualistic-thinking-2767-5558/ 2023-09-26T18:56:29+00:00 https://de.pi-multilingual.rt.gw/section/mindbody-integration-in-psychiatric-care-2767-5559/ 2023-09-26T18:56:29+00:00 https://de.pi-multilingual.rt.gw/section/knowing-the-patient-2767-5560/ 2023-09-26T18:56:29+00:00 https://de.pi-multilingual.rt.gw/section/attending-the-patients-ambivalence-2767-5561/ 2023-09-26T18:56:29+00:00 https://de.pi-multilingual.rt.gw/section/cultivating-a-therapeutic-alliance-2767-5562/ 2023-09-26T18:56:30+00:00 https://de.pi-multilingual.rt.gw/section/addressing-countertherapeutic-uses-of-medication-and-countertransference-2767-5563/ 2023-09-26T18:56:30+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignettes-2767-5564/ 2023-09-26T18:56:30+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2767-5565/ 2023-09-26T18:56:30+00:00 https://de.pi-multilingual.rt.gw/section/medications-during-breastfeeding-guidelines-and-labels-2615-5071/ 2023-10-25T18:02:44+00:00 https://de.pi-multilingual.rt.gw/section/side-effects-pharmacokinetics-and-prescribing-information-2338-4465/ 2023-10-30T21:20:03+00:00 https://de.pi-multilingual.rt.gw/section/exploring-the-evidence-of-n-acetyl-cysteine-nac-for-mood-disorders-2768-5582/ 2023-10-31T21:29:44+00:00 https://de.pi-multilingual.rt.gw/section/evidence-for-nac-in-other-psychiatric-disorders-2768-5583/ 2023-10-31T21:29:44+00:00 https://de.pi-multilingual.rt.gw/section/cannabidiol-evidence-for-psychiatric-disorders-and-recommendations-for-using-it-2768-5585/ 2023-10-31T21:29:44+00:00 https://de.pi-multilingual.rt.gw/section/use-of-folic-acid-and-l-methylfolate-in-psychiatric-disorders-2768-5586/ 2023-10-31T21:29:44+00:00 https://de.pi-multilingual.rt.gw/section/an-introduction-to-the-use-of-natural-medication-for-psychiatric-disorders-2768-5581/ 2023-10-31T21:29:44+00:00 https://de.pi-multilingual.rt.gw/section/ashwagandha-asw-potential-indications-and-administration-in-psychiatric-disorders-2768-5587/ 2023-10-31T21:29:45+00:00 https://de.pi-multilingual.rt.gw/section/potential-combinations-of-natural-medication-for-psychiatric-disorders-2768-5588/ 2023-10-31T21:29:45+00:00 https://de.pi-multilingual.rt.gw/section/recommendations-for-using-natural-medication-in-psychiatric-disorders-2768-5589/ 2023-10-31T21:29:45+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2768-5590/ 2023-10-31T21:29:45+00:00 https://de.pi-multilingual.rt.gw/section/inositol-potential-indications-administration-and-a-clinical-vignette-2768-5584/ 2023-10-31T21:42:50+00:00 https://de.pi-multilingual.rt.gw/section/adverse-effects-of-2-adrenergic-agonists-and-stimulants-in-preschool-age-adhd-2780-5576/ 2023-10-31T21:56:38+00:00 https://de.pi-multilingual.rt.gw/section/in-utero-exposure-to-adhd-medication-and-long-term-offspring-outcomes-2780-5577/ 2023-10-31T21:56:38+00:00 https://de.pi-multilingual.rt.gw/section/early-childhood-general-anesthesia-and-risk-of-adhd-2780-5579/ 2023-10-31T21:56:38+00:00 https://de.pi-multilingual.rt.gw/section/is-fish-oil-effective-in-youth-depression-2780-5578/ 2023-11-23T16:22:09+00:00 https://de.pi-multilingual.rt.gw/section/adolescent-depression-and-anxiety-symptoms-during-the-covid-19-pandemic-2781-5598/ 2023-11-29T19:40:07+00:00 https://de.pi-multilingual.rt.gw/section/adoption-of-vaping-cessation-methods-by-us-adolescents-2781-5599/ 2023-11-29T19:44:50+00:00 https://de.pi-multilingual.rt.gw/section/pediatric-adhd-medication-errors-reported-to-united-states-poison-centers-2781-5600/ 2023-11-29T19:51:11+00:00 https://de.pi-multilingual.rt.gw/section/learning-the-basics-of-sleep-2765-5601/ 2023-12-01T01:01:29+00:00 https://de.pi-multilingual.rt.gw/section/diagnostic-approaches-and-assessment-strategies-for-insomnia-2765-5603/ 2023-12-01T01:01:29+00:00 https://de.pi-multilingual.rt.gw/section/nonpharmacologic-interventions-for-insomnia-2765-5604/ 2023-12-01T01:01:30+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-interventions-for-insomnia-benzodiazepines-and-non-benzodiazepine-hypnotics-2765-5605/ 2023-12-01T01:01:30+00:00 https://de.pi-multilingual.rt.gw/section/treatment-strategies-for-managing-insomnia-in-mdd-2765-5607/ 2023-12-01T01:01:30+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignette-mr-b-2765-5609/ 2023-12-01T01:01:30+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2765-5610/ 2023-12-01T01:01:30+00:00 https://de.pi-multilingual.rt.gw/section/other-pharmacologic-interventions-for-insomnia-2765-5606/ 2023-12-01T01:34:10+00:00 https://de.pi-multilingual.rt.gw/section/role-of-ketamine-and-neurostimulation-treatments-in-insomnia-comorbid-with-mdd-2765-5608/ 2023-12-01T19:48:52+00:00 https://de.pi-multilingual.rt.gw/section/understanding-the-relationship-between-insomnia-disorder-and-mdd-2765-5602/ 2023-12-01T19:55:48+00:00 https://de.pi-multilingual.rt.gw/section/association-of-benzodiazepines-with-drug-overdose-risk-among-young-people-2780-5580/ 2023-12-18T14:38:47+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-methylphenidate-on-pain-perception-thresholds-in-children-with-adhd-2781-5596/ 2023-12-25T19:55:59+00:00 https://de.pi-multilingual.rt.gw/section/the-science-of-the-art-of-psychopharmacotherapy-2784-5611/ 2023-12-28T17:00:44+00:00 https://de.pi-multilingual.rt.gw/section/the-biological-theory-of-illness-and-stigma-2784-5612/ 2023-12-28T18:53:38+00:00 https://de.pi-multilingual.rt.gw/section/pharmacotherapy-alliance-treatment-preferences-and-communication-2784-5613/ 2023-12-28T18:53:38+00:00 https://de.pi-multilingual.rt.gw/section/psychotherapy-skills-in-everyday-practice-ordinary-medical-psychotherapy-2784-5614/ 2023-12-28T18:53:38+00:00 https://de.pi-multilingual.rt.gw/section/the-case-of-m-part-1-2784-5615/ 2023-12-28T18:53:38+00:00 https://de.pi-multilingual.rt.gw/section/the-case-of-m-part-2-2784-5616/ 2023-12-28T18:53:38+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2784-5617/ 2023-12-28T18:53:38+00:00 https://de.pi-multilingual.rt.gw/section/development-and-external-validation-of-the-psychosis-metabolic-risk-calculator-psymetric-a-cardiometabolic-risk-prediction-algorithm-for-young-people-with-psychosis-2612-5096/ 2024-01-11T00:46:44+00:00 https://de.pi-multilingual.rt.gw/section/six-month-neurological-and-psychiatric-outcomes-in-236379-survivors-of-covid-19-a-retrospective-cohort-study-using-electronic-health-records-2612-5097/ 2024-01-11T00:58:59+00:00 https://de.pi-multilingual.rt.gw/section/venlafaxine-vs-fluoxetine-in-postmenopausal-women-with-major-depressive-disorder-an-8-week-randomized-single-blind-active-controlled-study-2612-5098/ 2024-01-11T00:58:59+00:00 https://de.pi-multilingual.rt.gw/section/agitation-and-dementia-prevention-and-treatment-strategies-in-acute-and-chronic-conditions-2612-5099/ 2024-01-11T00:58:59+00:00 https://de.pi-multilingual.rt.gw/section/a-systematic-review-of-complex-polypharmacy-in-bipolar-disorder-prevalence-clinical-features-adherence-and-preliminary-recommendations-for-practitioners-2612-5100/ 2024-01-11T00:58:59+00:00 https://de.pi-multilingual.rt.gw/section/insomnia-symptoms-and-the-risk-of-stroke-in-the-health-and-retirement-study-2778-5623/ 2024-01-11T21:36:33+00:00 https://de.pi-multilingual.rt.gw/section/comparative-safety-of-oral-antipsychotics-for-adverse-events-in-adults-after-surgery-2778-5625/ 2024-01-11T21:46:37+00:00 https://de.pi-multilingual.rt.gw/section/medical-cannabis-in-the-treatment-of-parkinsons-disease-2778-5626/ 2024-01-11T21:50:57+00:00 https://de.pi-multilingual.rt.gw/section/prevalence-of-neuroradiological-abnormalities-in-first-episode-psychosis-2778-5627/ 2024-01-11T21:56:30+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-escitalopram-in-treating-generalized-anxiety-disorder-in-youth-2782-5628/ 2024-01-18T23:03:01+00:00 https://de.pi-multilingual.rt.gw/section/vortioxetines-impact-on-sleep-architecture-in-depressed-adolescents-2782-5629/ 2024-01-18T23:08:03+00:00 https://de.pi-multilingual.rt.gw/section/esketamine-a-potential-alternative-treatment-for-youth-depression-and-its-cognitive-effects-2782-5631/ 2024-01-18T23:32:39+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-risperidone-as-treatment-for-anorexia-nervosa-2782-5632/ 2024-01-19T17:20:41+00:00 https://de.pi-multilingual.rt.gw/section/exploring-aripiprazole-lauroxil-use-in-adolescent-psychiatry-2782-5630/ 2024-01-20T01:27:42+00:00 https://de.pi-multilingual.rt.gw/section/exploring-lamotrigine-indications-and-off-label-uses-2791-5633/ 2024-02-01T02:07:11+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-side-effects-and-special-considerations-2791-5635/ 2024-02-01T02:07:11+00:00 https://de.pi-multilingual.rt.gw/section/other-cardiac-complications-associated-with-lamotrigine-use-2791-5638/ 2024-02-01T02:07:11+00:00 https://de.pi-multilingual.rt.gw/section/a-practical-approach-in-ms-as-case-2791-5640/ 2024-02-01T02:07:12+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2791-5641/ 2024-02-01T02:07:12+00:00 https://de.pi-multilingual.rt.gw/section/exploring-potential-cardiac-side-effects-of-lamotrigine-and-ms-a-case-2791-5636/ 2024-02-01T02:15:05+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-effect-on-qtc-prolongation-and-qrs-widening-2791-5637/ 2024-02-01T02:18:57+00:00 https://de.pi-multilingual.rt.gw/section/strategies-for-safe-usage-and-proper-monitoring-of-lamotrigine-2791-5639/ 2024-02-01T02:25:30+00:00 https://de.pi-multilingual.rt.gw/section/cariprazine-for-the-adjunctive-treatment-of-major-depressive-disorder-2788-5652/ 2024-02-21T21:52:10+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-low-dose-risperidone-for-postsurgical-delirium-in-elderly-patients-2788-5653/ 2024-02-21T21:58:52+00:00 https://de.pi-multilingual.rt.gw/section/psychiatric-disorders-and-subsequent-risk-of-cardiovascular-disease-2788-5655/ 2024-02-21T22:17:48+00:00 https://de.pi-multilingual.rt.gw/section/real-world-effectiveness-of-pharmacologic-treatments-for-bipolar-disorder-2788-5656/ 2024-02-21T22:22:28+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-memantine-in-treating-trichotillomania-and-skin-picking-disorder-2788-5654/ 2024-02-22T00:25:34+00:00 https://de.pi-multilingual.rt.gw/section/the-psychopharmacology-of-agitation-managing-behavioral-emergencies-2786-5642/ 2024-02-22T21:37:05+00:00 https://de.pi-multilingual.rt.gw/section/psychiatric-diagnoses-in-agitated-patients-delirium-dementia-and-psychotic-disorders-2786-5644/ 2024-02-22T21:37:06+00:00 https://de.pi-multilingual.rt.gw/section/other-psychiatric-diagnoses-in-agitated-patients-mood-and-substance-use-disorders-2786-5645/ 2024-02-22T21:37:06+00:00 https://de.pi-multilingual.rt.gw/section/nonpharmacologic-strategies-for-managing-agitation-verbal-de-escalation-2786-5646/ 2024-02-22T21:37:06+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-strategies-for-managing-agitation-general-recommendations-and-treatments-goals-2786-5647/ 2024-02-22T21:37:06+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-antipsychotics-in-managing-agitation-2786-5648/ 2024-02-22T21:37:06+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-benzodiazepines-and-dexmedetomidine-in-managing-agitation-2786-5649/ 2024-02-22T21:37:06+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignette-an-alternative-approach-to-agitated-patients-2786-5650/ 2024-02-22T21:37:07+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2786-5651/ 2024-02-22T21:37:07+00:00 https://de.pi-multilingual.rt.gw/section/long-term-efficacy-of-antipsychotic-drugs-in-adults-with-schizophrenia-2778-5624/ 2024-02-24T03:17:07+00:00 https://de.pi-multilingual.rt.gw/section/ssrisnri-concentrations-after-bariatric-surgery-and-effects-on-depressive-symptoms-2777-5618/ 2024-02-27T23:06:34+00:00 https://de.pi-multilingual.rt.gw/section/psychedelics-as-transformative-therapeutics-2777-5619/ 2024-02-27T23:06:34+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-use-in-patients-with-comorbid-depression-and-medical-illness-2777-5620/ 2024-02-27T23:06:34+00:00 https://de.pi-multilingual.rt.gw/section/use-of-daridorexant-for-the-management-of-chronic-insomnia-2777-5621/ 2024-02-27T23:06:34+00:00 https://de.pi-multilingual.rt.gw/section/an-international-research-agenda-for-clozapine-resistant-schizophrenia-2777-5622/ 2024-02-27T23:06:34+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-drugs-and-risk-of-acute-pancreatitis-2776-5591/ 2024-02-27T23:39:30+00:00 https://de.pi-multilingual.rt.gw/section/clozapine-and-its-augmentation-with-ect-in-ultra-treatment-resistant-schizophrenia-2776-5592/ 2024-02-27T23:39:30+00:00 https://de.pi-multilingual.rt.gw/section/risk-for-suicide-attempts-and-suicide-associated-with-benzodiazepines-2776-5593/ 2024-02-27T23:39:30+00:00 https://de.pi-multilingual.rt.gw/section/potential-benefits-of-silexan-for-post-covid-19-syndrome-2776-5594/ 2024-02-27T23:39:30+00:00 https://de.pi-multilingual.rt.gw/section/should-trazodone-be-first-line-therapy-for-insomnia-2776-5595/ 2024-02-27T23:39:30+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-discontinuation-during-pregnancy-and-postpartum-psychiatric-outcomes-2775-5572/ 2024-02-28T00:09:09+00:00 https://de.pi-multilingual.rt.gw/section/lithium-augmentation-for-treating-major-depressive-disorder-2775-5573/ 2024-02-28T00:09:09+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-safety-in-liver-disease-2775-5574/ 2024-02-28T00:09:09+00:00 https://de.pi-multilingual.rt.gw/section/polypharmacy-and-inappropriate-medications-with-antidepressants-in-older-adults-2775-5575/ 2024-02-28T00:09:10+00:00 https://de.pi-multilingual.rt.gw/section/tobacco-use-nicotine-dependence-and-cessation-among-adults-with-psychosis-2774-5566/ 2024-02-28T01:13:13+00:00 https://de.pi-multilingual.rt.gw/section/the-pharmacologic-treatment-of-obsessive-compulsive-disorder-2774-5567/ 2024-02-28T01:13:13+00:00 https://de.pi-multilingual.rt.gw/section/risk-of-irreversible-postssri-sexual-dysfunction-with-antidepressants-2774-5568/ 2024-02-28T01:13:13+00:00 https://de.pi-multilingual.rt.gw/section/delirium-preventive-effects-of-dual-orexin-receptor-antagonists-2774-5569/ 2024-02-28T01:13:14+00:00 https://de.pi-multilingual.rt.gw/section/sleep-disorders-in-parkinsons-disease-2774-5570/ 2024-02-28T01:13:14+00:00 https://de.pi-multilingual.rt.gw/section/victimization-in-relation-to-violence-in-schizophrenia-2738-5543/ 2024-02-28T01:36:28+00:00 https://de.pi-multilingual.rt.gw/section/zuranolone-for-the-treatment-of-postpartum-depression-2738-5544/ 2024-02-28T01:36:28+00:00 https://de.pi-multilingual.rt.gw/section/apathy-associated-with-antidepressant-drugs-2738-5545/ 2024-02-28T01:36:29+00:00 https://de.pi-multilingual.rt.gw/section/risk-of-malformations-in-infants-after-exposure-to-benzodiazepines-2738-5546/ 2024-02-28T01:36:29+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-brexanolone-on-postpartum-depressive-symptoms-anxiety-and-insomnia-2737-5503/ 2024-02-28T02:08:58+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-aripiprazole-co-prescription-on-prolactin-levels-in-schizophrenic-patients-with-type-2-diabetes-2737-5504/ 2024-02-28T02:08:58+00:00 https://de.pi-multilingual.rt.gw/section/tardive-syndromes-clinical-manifestations-and-treatment-strategies-2737-5505/ 2024-02-28T02:08:58+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-pharmacogenomics-testing-on-clinical-outcomes-in-major-depressive-disorder-2737-5506/ 2024-02-28T02:08:58+00:00 https://de.pi-multilingual.rt.gw/section/the-impact-of-colony-stimulating-factor-on-clozapine-rechallenge-outcomes-2737-5507/ 2024-02-28T02:08:58+00:00 https://de.pi-multilingual.rt.gw/section/cades-disease-and-beyond-misdiagnosis-antidepressant-use-and-a-proposed-definition-for-bipolar-spectrum-disorder-2731-5498/ 2024-02-28T02:38:38+00:00 https://de.pi-multilingual.rt.gw/section/canadian-network-for-mood-and-anxiety-treatments-canmat-and-international-society-for-bipolar-disorders-isbd-recommendations-for-the-management-of-patients-with-bipolar-disorder-with-mixed-presentatio/ 2024-02-28T02:38:38+00:00 https://de.pi-multilingual.rt.gw/section/considering-the-methodological-limitations-in-the-evidence-base-of-antidepressants-for-depression-a-reanalysis-of-a-network-meta-analysis-2731-5500/ 2024-02-28T02:38:38+00:00 https://de.pi-multilingual.rt.gw/section/distinguishing-relapse-from-antidepressant-withdrawal-clinical-practice-and-antidepressant-discontinuation-studies-2731-5501/ 2024-02-28T02:38:38+00:00 https://de.pi-multilingual.rt.gw/section/canadian-network-for-mood-and-anxiety-treatments-canmat-and-international-society-for-bipolar-disorders-isbd-2018-guidelines-for-the-management-of-patients-with-bipolar-disorder-2731-5502/ 2024-02-28T02:38:38+00:00 https://de.pi-multilingual.rt.gw/section/comparative-efficacy-safety-and-acceptability-of-pimavanserin-and-other-atypical-antipsychotics-for-parkinsons-disease-psychosis-systematic-review-and-network-meta-analysis-2726-5477/ 2024-02-28T03:13:24+00:00 https://de.pi-multilingual.rt.gw/section/dual-orexin-receptor-antagonists-for-the-treatment-of-insomnia-a-systematic-review-and-meta-analysis-on-randomized-double-blind-placebo-controlled-trials-of-suvorexant-and-lemborexant-2726-5478/ 2024-02-28T03:13:24+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-treatments-for-cocaine-craving-what-is-the-way-forward-a-systematic-review-2726-5479/ 2024-02-28T03:13:24+00:00 https://de.pi-multilingual.rt.gw/section/third-generation-antipsychotics-in-patients-with-schizophrenia-and-nonresponsivity-or-intolerance-to-clozapine-regimen-what-is-the-evidence-2726-5480/ 2024-02-28T03:13:24+00:00 https://de.pi-multilingual.rt.gw/section/olanzapinesamidorphan-in-young-adults-with-schizophrenia-schizophreniform-disorder-or-bipolar-i-disorder-who-are-early-in-their-illness-results-of-the-randomized-controlled-enlighten-early-study-2726/ 2024-02-28T03:13:24+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-use-during-pregnancy-and-the-risk-for-gestational-diabetes-a-systematic-review-and-meta-analysis-2708-5451/ 2024-02-28T03:47:50+00:00 https://de.pi-multilingual.rt.gw/section/risk-of-cardiovascular-diseases-associated-with-medications-used-in-attention-deficithyperactivity-disorder-a-systematic-review-and-meta-analysis-2708-5452/ 2024-02-28T03:47:51+00:00 https://de.pi-multilingual.rt.gw/section/cannabis-connectivity-and-coming-of-age-associations-between-cannabis-use-and-anterior-cingulate-cortex-connectivity-during-the-transition-to-adulthood-2708-5453/ 2024-02-28T03:47:51+00:00 https://de.pi-multilingual.rt.gw/section/use-of-hormonal-contraceptives-and-antidepressants-and-risks-of-suicidal-behavior-and-accidents-among-women-with-premenstrual-disorders-a-nationwide-cohort-study-2708-5454/ 2024-02-28T03:47:51+00:00 https://de.pi-multilingual.rt.gw/section/associations-between-antipsychotic-use-substance-use-and-relapse-risk-in-patients-with-schizophrenia-real-world-evidence-from-2-national-cohorts-2707-5429/ 2024-02-28T16:54:28+00:00 https://de.pi-multilingual.rt.gw/section/novel-and-emerging-treatments-for-major-depression-2707-5430/ 2024-02-28T16:54:28+00:00 https://de.pi-multilingual.rt.gw/section/effects-of-a-smartphone-based-self-management-intervention-for-individuals-with-bipolar-disorder-on-relapse-symptom-burden-and-quality-of-life-2707-5431/ 2024-02-28T16:54:28+00:00 https://de.pi-multilingual.rt.gw/section/e-cigarette-use-patterns-flavors-and-device-characteristics-associated-with-quitting-smoking-among-a-us-sample-of-adults-using-e-cigarettes-in-a-smoking-cessation-attempt-2707-5432/ 2024-02-28T16:54:29+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-pharmacogenomic-testing-for-druggene-interactions-on-medication-selection-and-remission-of-symptoms-in-major-depressive-disorder-the-prime-care-randomized-clinical-trial-2707-5433/ 2024-02-28T16:54:29+00:00 https://de.pi-multilingual.rt.gw/section/cognitive-function-and-treatment-response-trajectories-in-first-episode-schizophrenia-evidence-from-a-prospective-cohort-study-2706-5397/ 2024-02-28T17:40:19+00:00 https://de.pi-multilingual.rt.gw/section/antidepressants-for-the-treatment-of-adults-with-major-depressive-disorder-in-the-maintenance-phase-a-systematic-review-and-network-meta-analysis-2706-5398/ 2024-02-28T17:40:19+00:00 https://de.pi-multilingual.rt.gw/section/augmentation-strategies-for-clozapine-resistance-a-systematic-review-and-meta-analysis-2706-5399/ 2024-02-28T17:40:20+00:00 https://de.pi-multilingual.rt.gw/section/c-reactive-protein-could-predict-the-efficacy-of-ssris-in-clinical-practice-a-cohort-study-of-large-samples-in-the-real-world-2706-5400/ 2024-02-28T17:40:20+00:00 https://de.pi-multilingual.rt.gw/section/effect-of-anxiolytic-drug-silexan-on-sleep-a-narrative-review-2706-5401/ 2024-02-28T17:40:20+00:00 https://de.pi-multilingual.rt.gw/section/assessing-agitation-medical-evaluation-rating-scales-and-differential-diagnosis-2786-5643/ 2024-03-01T03:16:55+00:00 https://de.pi-multilingual.rt.gw/section/remission-and-relapse-in-pediatric-obsessive-compulsive-disorder-2783-5657/ 2024-03-20T19:49:22+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-probiotics-in-treating-adhd-symptoms-2783-5658/ 2024-03-20T19:54:00+00:00 https://de.pi-multilingual.rt.gw/section/electroconvulsive-therapy-for-adolescents-with-severe-depression-and-suicidality-2783-5659/ 2024-03-20T19:58:59+00:00 https://de.pi-multilingual.rt.gw/section/noninvasive-brain-stimulation-in-children-2783-5660/ 2024-03-20T20:03:27+00:00 https://de.pi-multilingual.rt.gw/section/revisiting-droperidol-for-managing-agitation-2794-5662/ 2024-03-20T20:30:37+00:00 https://de.pi-multilingual.rt.gw/section/understanding-the-interaction-between-antidepressants-and-psychotherapy-2794-5663/ 2024-03-20T20:36:04+00:00 https://de.pi-multilingual.rt.gw/section/stopping-benzodiazepines-and-z-drugs-in-hospitalized-elderly-patients-2794-5664/ 2024-03-20T20:41:17+00:00 https://de.pi-multilingual.rt.gw/section/anosmia-in-covid-19-patients-impacts-and-potential-treatments-2794-5665/ 2024-03-20T20:46:44+00:00 https://de.pi-multilingual.rt.gw/section/long-term-efficacy-of-escitalopram-in-adolescents-with-major-depressive-disorder-2783-5661/ 2024-03-22T22:29:32+00:00 https://de.pi-multilingual.rt.gw/section/understanding-the-basics-of-tms-2792-5667/ 2024-03-28T19:37:11+00:00 https://de.pi-multilingual.rt.gw/section/fda-approved-tms-devices-and-coils-2792-5668/ 2024-03-28T19:37:11+00:00 https://de.pi-multilingual.rt.gw/section/the-science-behind-tms-brain-circuits-2792-5669/ 2024-03-28T19:37:11+00:00 https://de.pi-multilingual.rt.gw/section/assessing-the-potential-side-effects-of-tms-2792-5670/ 2024-03-28T19:37:11+00:00 https://de.pi-multilingual.rt.gw/section/exploring-the-evidence-of-tms-for-depression-2792-5671/ 2024-03-28T19:37:11+00:00 https://de.pi-multilingual.rt.gw/section/exploring-the-evidence-of-tms-for-ocd-2792-5672/ 2024-03-28T19:37:12+00:00 https://de.pi-multilingual.rt.gw/section/recent-innovations-in-tms-research-and-practice-2792-5673/ 2024-03-28T19:37:12+00:00 https://de.pi-multilingual.rt.gw/section/optimizing-patient-selection-for-tms-treatment-2792-5674/ 2024-03-28T19:37:12+00:00 https://de.pi-multilingual.rt.gw/section/exploring-other-uses-of-tms-2792-5675/ 2024-03-28T19:37:12+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-2792-5676/ 2024-03-28T19:37:12+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2792-5677/ 2024-03-28T19:37:12+00:00 https://de.pi-multilingual.rt.gw/section/is-high-dose-olanzapine-an-option-for-treatment-resistant-schizophrenia-2794-5666/ 2024-03-30T00:58:49+00:00 https://de.pi-multilingual.rt.gw/section/persistence-of-autism-spectrum-disorder-from-early-childhood-through-school-age-2781-5597/ 2024-04-10T00:18:47+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-dose-reduction-in-schizophrenia-insights-from-the-radar-trial-2801-5689/ 2024-04-23T00:04:25+00:00 https://de.pi-multilingual.rt.gw/section/famotidine-for-covid-19-brain-fog-a-promising-treatment-option-2801-5691/ 2024-04-23T00:18:34+00:00 https://de.pi-multilingual.rt.gw/section/long-acting-injectable-antipsychotics-for-bipolar-disorder-real-world-evidence-2801-5692/ 2024-04-23T00:23:22+00:00 https://de.pi-multilingual.rt.gw/section/advancements-in-treating-psychiatric-disorders-with-psilocybin-2801-5690/ 2024-04-23T00:28:37+00:00 https://de.pi-multilingual.rt.gw/section/poststroke-depression-recognizing-and-managing-mood-symptoms-2801-5693/ 2024-04-23T00:28:37+00:00 https://de.pi-multilingual.rt.gw/section/benzodiazepines-tracing-their-history-2797-5678/ 2024-04-25T17:06:11+00:00 https://de.pi-multilingual.rt.gw/section/benzodiazepines-neuropharmacology-and-tolerance-development-2797-5679/ 2024-04-25T17:06:12+00:00 https://de.pi-multilingual.rt.gw/section/understanding-the-major-risks-of-benzodiazepine-use-2797-5682/ 2024-04-25T17:06:12+00:00 https://de.pi-multilingual.rt.gw/section/the-benzodiazepine-crisis-overprescription-physical-dependence-misuse-and-addiction-2797-5683/ 2024-04-25T17:06:12+00:00 https://de.pi-multilingual.rt.gw/section/benzodiazepine-use-disorder-2797-5684/ 2024-04-25T17:06:12+00:00 https://de.pi-multilingual.rt.gw/section/consequences-of-benzodiazepine-use-in-pregnancy-breastfeeding-and-adolescence-2797-5686/ 2024-04-25T17:06:12+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignette-strategies-for-safer-use-of-benzodiazepines-2797-5687/ 2024-04-25T17:06:13+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2797-5688/ 2024-04-25T17:06:13+00:00 https://de.pi-multilingual.rt.gw/section/appropriate-benzodiazepine-use-indications-and-optimal-selection-2797-5680/ 2024-05-01T00:58:44+00:00 https://de.pi-multilingual.rt.gw/section/risks-of-benzodiazepines-contraindications-and-side-effects-2797-5681/ 2024-05-01T00:59:44+00:00 https://de.pi-multilingual.rt.gw/section/consequences-of-benzodiazepine-use-in-high-risk-populations-2797-5685/ 2024-05-01T01:10:19+00:00 https://de.pi-multilingual.rt.gw/section/long-term-effects-of-methylphenidate-on-sleep-in-children-and-adolescents-with-adhd-2789-5695/ 2024-05-23T00:32:53+00:00 https://de.pi-multilingual.rt.gw/section/deep-transcranial-magnetic-stimulation-a-promising-treatment-for-treatment-resistant-depression-in-adolescents-2789-5696/ 2024-05-23T00:38:26+00:00 https://de.pi-multilingual.rt.gw/section/cardiac-and-metabolic-safety-profile-of-antipsychotics-in-youth-2789-5697/ 2024-05-23T00:44:55+00:00 https://de.pi-multilingual.rt.gw/section/sleep-medication-prescribing-tendencies-in-youth-with-insomnia-2789-5698/ 2024-05-23T00:52:29+00:00 https://de.pi-multilingual.rt.gw/section/improving-outcomes-in-early-onset-schizophrenia-2789-5699/ 2024-05-23T00:58:19+00:00 https://de.pi-multilingual.rt.gw/section/xanomeline-trospium-karxt-shows-efficacy-in-phase-3-trial-for-schizophrenia-2802-5700/ 2024-05-30T17:32:07+00:00 https://de.pi-multilingual.rt.gw/section/reducing-restraint-bias-in-psychiatric-emergency-rooms-2802-5701/ 2024-05-30T17:38:19+00:00 https://de.pi-multilingual.rt.gw/section/transition-to-schizophrenia-after-a-substance-use-disorder-2802-5702/ 2024-05-30T17:44:38+00:00 https://de.pi-multilingual.rt.gw/section/predicting-conversion-to-psychosis-using-machine-learning-2802-5703/ 2024-05-30T17:59:33+00:00 https://de.pi-multilingual.rt.gw/section/iloperidone-a-potential-treatment-option-for-bipolar-mania-2802-5704/ 2024-05-30T17:59:33+00:00 https://de.pi-multilingual.rt.gw/section/motivational-interviewing-strategies-for-benzodiazepine-users-2798-5705/ 2024-06-01T02:06:24+00:00 https://de.pi-multilingual.rt.gw/section/benzodiazepine-deprescription-indications-benefits-and-risks-2798-5706/ 2024-06-01T02:06:24+00:00 https://de.pi-multilingual.rt.gw/section/understanding-the-principles-of-benzodiazepine-tapering-2798-5707/ 2024-06-01T02:06:24+00:00 https://de.pi-multilingual.rt.gw/section/techniques-for-successful-benzodiazepine-tapering-2798-5708/ 2024-06-01T02:06:24+00:00 https://de.pi-multilingual.rt.gw/section/understanding-and-managing-benzodiazepine-withdrawal-symptoms-2798-5709/ 2024-06-01T02:06:24+00:00 https://de.pi-multilingual.rt.gw/section/exploring-the-complexities-of-benzodiazepine-induced-neurological-dysfunction-bind-2798-5710/ 2024-06-01T02:06:25+00:00 https://de.pi-multilingual.rt.gw/section/beyond-benzodiazepine-discontinuation-understanding-life-effects-and-support-strategies-2798-5711/ 2024-06-01T02:06:25+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-2798-5712/ 2024-06-01T02:06:25+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2798-5713/ 2024-06-01T02:26:21+00:00 https://de.pi-multilingual.rt.gw/section/hypochondriasis-linked-to-increased-mortality-risk-2809-5722/ 2024-06-29T01:56:56+00:00 https://de.pi-multilingual.rt.gw/section/amphetamine-and-methylphenidate-in-pregnancy-is-there-an-increased-risk-of-neurodevelopmental-disorders-2809-5723/ 2024-06-29T01:56:56+00:00 https://de.pi-multilingual.rt.gw/section/insomnia-in-the-elderly-do-sedatives-increase-or-decrease-fall-risk-2809-5724/ 2024-06-29T01:56:56+00:00 https://de.pi-multilingual.rt.gw/section/can-probiotics-treat-schizophrenia-exploring-the-gut-brain-connection-2809-5725/ 2024-06-29T01:56:57+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-withdrawal-syndrome-symptoms-risks-and-prevention-strategies-2809-5726/ 2024-06-29T01:56:57+00:00 https://de.pi-multilingual.rt.gw/section/introducing-the-psychopharmacology-algorithm-for-bipolar-mania-2814-5714/ 2024-06-29T01:58:19+00:00 https://de.pi-multilingual.rt.gw/section/diagnosing-bipolar-mania-and-comorbid-disorders-2814-5715/ 2024-06-29T01:58:20+00:00 https://de.pi-multilingual.rt.gw/section/managing-bipolar-mania-with-mixed-features-sgas-2814-5716/ 2024-06-29T01:58:20+00:00 https://de.pi-multilingual.rt.gw/section/choosing-between-valproate-or-lithium-augmentation-for-bipolar-mania-with-mixed-features-2814-5717/ 2024-06-29T01:58:20+00:00 https://de.pi-multilingual.rt.gw/section/lithium-for-bipolar-mania-without-mixed-features-2814-5718/ 2024-06-29T01:58:20+00:00 https://de.pi-multilingual.rt.gw/section/augmenting-with-sgas-after-unsatisfactory-response-to-lithium-in-bipolar-mania-2814-5719/ 2024-06-29T01:58:20+00:00 https://de.pi-multilingual.rt.gw/section/other-pharmacologic-options-and-ect-for-managing-bipolar-mania-2814-5720/ 2024-06-29T01:58:20+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2814-5721/ 2024-06-29T01:58:20+00:00 https://de.pi-multilingual.rt.gw/section/an-overview-of-substance-use-and-opioid-misuse-2807-5727/ 2024-07-30T22:35:40+00:00 https://de.pi-multilingual.rt.gw/section/understanding-opioid-intoxication-and-withdrawal-2807-5728/ 2024-07-30T22:35:41+00:00 https://de.pi-multilingual.rt.gw/section/a-comprehensive-guide-to-oud-treatment-2807-5729/ 2024-07-30T22:35:41+00:00 https://de.pi-multilingual.rt.gw/section/tailored-patient-assessment-a-key-to-effective-oud-treatment-2807-5730/ 2024-07-30T22:35:41+00:00 https://de.pi-multilingual.rt.gw/section/methadone-for-managing-oud-2807-5731/ 2024-07-30T22:35:41+00:00 https://de.pi-multilingual.rt.gw/section/buprenorphine-for-managing-oud-2807-5732/ 2024-07-30T22:35:41+00:00 https://de.pi-multilingual.rt.gw/section/examining-the-efficacy-of-extended-release-naltrexone-oud-2807-5733/ 2024-07-30T22:35:41+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-naloxone-in-managing-oud-2807-5734/ 2024-07-30T22:35:41+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-initiating-buprenorphine-treatment-2807-5735/ 2024-07-30T22:35:42+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2807-5736/ 2024-07-30T22:35:42+00:00 https://de.pi-multilingual.rt.gw/section/do-benzodiazepine-users-escalate-doses-over-time-2817-5738/ 2024-07-31T21:17:33+00:00 https://de.pi-multilingual.rt.gw/section/do-antidepressants-improve-cognitive-symptoms-in-late-life-depression-2817-5739/ 2024-07-31T21:17:33+00:00 https://de.pi-multilingual.rt.gw/section/managing-psychosis-agitation-and-depression-in-patients-with-dementia-2817-5740/ 2024-07-31T21:17:33+00:00 https://de.pi-multilingual.rt.gw/section/geriatric-depression-ranking-antidepressant-efficacy-tolerability-and-outcomes-2817-5741/ 2024-07-31T21:17:33+00:00 https://de.pi-multilingual.rt.gw/section/can-ssris-be-safely-prescribed-with-oral-anticoagulants-2817-5737/ 2024-07-31T21:20:18+00:00 https://de.pi-multilingual.rt.gw/section/introduction-to-clozapine-indications-and-common-adverse-effects-2733-5460/ 2024-08-27T14:52:56+00:00 https://de.pi-multilingual.rt.gw/section/using-clozapine-for-treatment-resistant-psychosis-and-mood-disorders-2733-5461/ 2024-08-27T14:52:56+00:00 https://de.pi-multilingual.rt.gw/section/using-clozapine-for-suicide-risk-and-aggression-2733-5462/ 2024-08-27T14:52:56+00:00 https://de.pi-multilingual.rt.gw/section/off-label-indications-for-clozapine-2733-5463/ 2024-08-27T14:52:56+00:00 https://de.pi-multilingual.rt.gw/section/pretreatment-evaluation-and-consent-for-using-clozapine-2733-5464/ 2024-08-27T14:52:56+00:00 https://de.pi-multilingual.rt.gw/section/initiating-and-optimizing-clozapine-2733-5465/ 2024-08-27T14:52:57+00:00 https://de.pi-multilingual.rt.gw/section/clozapine-monitoring-rems-system-2733-5466/ 2024-08-27T14:52:57+00:00 https://de.pi-multilingual.rt.gw/section/managing-fever-and-hematologic-adverse-effects-of-clozapine-2733-5467/ 2024-08-27T14:52:57+00:00 https://de.pi-multilingual.rt.gw/section/managing-cardiac-and-metabolic-adverse-effects-of-clozapine-2733-5468/ 2024-08-27T14:52:57+00:00 https://de.pi-multilingual.rt.gw/section/managing-other-common-adverse-effects-of-clozapine-2733-5469/ 2024-08-27T14:52:57+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignette-managing-side-effects-during-clozapine-titration-2733-5470/ 2024-08-27T14:52:57+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2733-5471/ 2024-08-27T14:52:57+00:00 https://de.pi-multilingual.rt.gw/section/understanding-pain-in-osteoarthritis-and-fibromyalgia-2734-5482/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/mechanistic-characterization-of-pain-2734-5483/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/diagnosing-fibromyalgia-2734-5484/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/centralized-pain-in-chronic-pain-conditions-2734-5485/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/pathophysiology-and-neuroimaging-of-centralized-pain-states-2734-5486/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-therapies-for-fibromyalgia-2734-5487/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/fibromyalgia-and-medical-cannabis-2734-5488/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/pain-treatments-tailored-to-underlying-mechanisms-2734-5489/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/nonpharmacologic-therapies-for-fibromyalgia-2734-5490/ 2024-08-27T14:55:06+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2734-5491/ 2024-08-27T14:55:07+00:00 https://de.pi-multilingual.rt.gw/section/can-donanemab-slow-alzheimers-progression-2818-5742/ 2024-08-27T16:30:59+00:00 https://de.pi-multilingual.rt.gw/section/does-clozapines-agranulocytosis-risk-persist-beyond-initial-treatment-period-2818-5743/ 2024-08-27T16:30:59+00:00 https://de.pi-multilingual.rt.gw/section/can-antipsychotics-cause-both-catatonia-and-nms-2818-5744/ 2024-08-27T16:30:59+00:00 https://de.pi-multilingual.rt.gw/section/parkinsons-disease-and-suicide-risk-what-clinicians-need-to-know-2818-5745/ 2024-08-27T16:30:59+00:00 https://de.pi-multilingual.rt.gw/section/can-ai-predict-antidepressant-response-and-remission-in-major-depression-2818-5746/ 2024-08-27T16:30:59+00:00 https://de.pi-multilingual.rt.gw/section/the-mechanisms-and-effects-of-psychedelics-2813-5748/ 2024-08-31T04:00:09+00:00 https://de.pi-multilingual.rt.gw/section/how-psychedelics-influence-brain-networks-2813-5749/ 2024-08-31T04:00:09+00:00 https://de.pi-multilingual.rt.gw/section/examining-the-combined-use-of-psychedelics-and-psychiatric-drugs-2813-5750/ 2024-08-31T04:00:09+00:00 https://de.pi-multilingual.rt.gw/section/psychedelic-assisted-therapy-in-clinical-practice-2813-5751/ 2024-08-31T04:00:10+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-psychedelic-assisted-therapies-in-treating-depression-2813-5752/ 2024-08-31T04:00:10+00:00 https://de.pi-multilingual.rt.gw/section/psychedelic-assisted-therapies-for-anxiety-and-alcohol-use-disorder-aud-2813-5753/ 2024-08-31T04:00:10+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignette-2813-5754/ 2024-08-31T04:00:10+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2813-5755/ 2024-08-31T04:00:10+00:00 https://de.pi-multilingual.rt.gw/section/olanzapine-induced-weight-gain-can-akkermansia-muciniphila-help-2830-5757/ 2024-09-25T00:25:00+00:00 https://de.pi-multilingual.rt.gw/section/how-does-climate-change-impact-mental-health-2830-5758/ 2024-09-25T00:25:00+00:00 https://de.pi-multilingual.rt.gw/section/can-antidrug-vaccines-treat-substance-use-disorders-2830-5759/ 2024-09-25T00:25:00+00:00 https://de.pi-multilingual.rt.gw/section/can-covid-19-infection-lead-to-a-loss-of-iq-points-2830-5760/ 2024-09-25T00:25:00+00:00 https://de.pi-multilingual.rt.gw/section/adult-adhd-understanding-prevalence-persistence-and-comorbidities-2835-5761/ 2024-10-01T01:16:32+00:00 https://de.pi-multilingual.rt.gw/section/adult-adhd-case-vignette-mr-jones-2835-5762/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/screening-for-adhd-what-should-clinicians-look-for-2835-5763/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/assessing-adult-adhd-clinical-interview-and-rating-scales-2835-5764/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/treatment-algorithm-for-adult-adhd-2835-5765/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-treatments-for-adult-adhd-focus-on-stimulants-2835-5766/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/stimulants-clinical-considerations-preventing-abuse-and-red-flags-2835-5767/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/nonstimulant-treatments-for-adult-adhd-2835-5768/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/psychotherapy-psychosocial-approaches-and-neurofeedback-for-adult-adhd-2835-5769/ 2024-10-01T01:16:33+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2835-5770/ 2024-10-01T01:16:34+00:00 https://de.pi-multilingual.rt.gw/section/which-antidepressants-have-the-highest-risk-of-discontinuation-symptoms-2830-5756/ 2024-10-01T01:31:10+00:00 https://de.pi-multilingual.rt.gw/section/drug-metabolism-the-importance-of-phase-i-and-ii-reactions-2334-4457/ 2024-10-12T07:39:31+00:00 https://de.pi-multilingual.rt.gw/section/exploring-emerging-trends-in-maternal-mortality-2826-5776/ 2024-10-25T04:41:10+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-differential-diagnosis-of-postpartum-mood-syndromes-2826-5777/ 2024-10-25T04:41:10+00:00 https://de.pi-multilingual.rt.gw/section/distinguishing-postpartum-blues-from-postpartum-depression-2826-5778/ 2024-10-25T04:41:10+00:00 https://de.pi-multilingual.rt.gw/section/postpartum-psychosis-identifying-and-assessing-a-psychiatric-emergency-2826-5779/ 2024-10-25T04:41:10+00:00 https://de.pi-multilingual.rt.gw/section/distinguishing-postpartum-ocd-from-postpartum-psychosis-2826-5780/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-recognizing-and-managing-postpartum-depression-2826-5781/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/treating-postpartum-depression-non-pharmacologic-strategies-2826-5782/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/postpartum-depression-pharmacologic-considerations-for-breastfeeding-mothers-2826-5783/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/tms-and-ect-effective-treatments-for-postpartum-mood-disorders-2826-5784/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-brexanolone-and-zuranolone-in-postpartum-depression-2826-5785/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/postpartum-psychosis-pharmacologic-strategies-2826-5786/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2826-5787/ 2024-10-25T04:41:11+00:00 https://de.pi-multilingual.rt.gw/section/can-vitamin-d-deficiency-increase-the-risk-of-alzheimers-disease-2831-5772/ 2024-10-25T21:43:30+00:00 https://de.pi-multilingual.rt.gw/section/can-lithium-protect-against-osteoporosis-2831-5773/ 2024-10-25T21:43:30+00:00 https://de.pi-multilingual.rt.gw/section/what-is-the-long-term-outcome-of-psychotic-disorders-2831-5775/ 2024-10-25T21:43:31+00:00 https://de.pi-multilingual.rt.gw/section/long-acting-antipsychotics-an-option-for-women-with-schizophrenia-2831-5771/ 2024-10-25T22:02:56+00:00 https://de.pi-multilingual.rt.gw/section/can-alcohol-withdrawal-syndrome-be-safely-treated-in-outpatient-settings-2831-5774/ 2024-10-25T22:02:56+00:00 https://de.pi-multilingual.rt.gw/section/clozapine-the-hidden-risks-of-ileus-and-pneumonia-2837-5788/ 2024-11-26T23:59:32+00:00 https://de.pi-multilingual.rt.gw/section/can-cariprazine-prevent-relapse-in-bipolar-i-disorder-2837-5790/ 2024-11-27T00:30:16+00:00 https://de.pi-multilingual.rt.gw/section/wernickes-encephalopathy-beyond-the-classic-triad-2837-5791/ 2024-11-27T00:41:36+00:00 https://de.pi-multilingual.rt.gw/section/depression-and-gut-bacteria-a-bidirectional-relationship-2837-5792/ 2024-11-27T00:54:43+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2827-5802/ 2024-11-30T00:25:44+00:00 https://de.pi-multilingual.rt.gw/section/understanding-pharmacokinetic-and-pharmacodynamic-genes-2827-5793/ 2024-11-30T00:52:57+00:00 https://de.pi-multilingual.rt.gw/section/how-do-pharmacokinetic-genes-influence-medication-metabolism-2827-5794/ 2024-11-30T00:52:57+00:00 https://de.pi-multilingual.rt.gw/section/pharmacogenetic-tests-that-matter-in-psychiatric-practice-2827-5795/ 2024-11-30T00:52:57+00:00 https://de.pi-multilingual.rt.gw/section/pharmacogenetics-guided-dosing-strategies-for-poor-and-rapid-metabolizers-2827-5796/ 2024-11-30T00:52:57+00:00 https://de.pi-multilingual.rt.gw/section/pharmacogenetic-panels-do-they-really-work-2827-5797/ 2024-11-30T00:52:58+00:00 https://de.pi-multilingual.rt.gw/section/sert-gene-and-ssri-response-is-it-clinically-useful-2827-5798/ 2024-11-30T00:52:58+00:00 https://de.pi-multilingual.rt.gw/section/mthfr-gene-the-weak-link-in-l-methylfolate-depression-treatment-2827-5799/ 2024-11-30T00:52:58+00:00 https://de.pi-multilingual.rt.gw/section/can-genetic-testing-cause-more-harm-than-good-2827-5800/ 2024-11-30T00:52:58+00:00 https://de.pi-multilingual.rt.gw/section/case-managing-citalopram-dosing-in-cyp2c19-poor-metabolizers-2827-5801/ 2024-11-30T00:52:58+00:00 https://de.pi-multilingual.rt.gw/section/can-topiramate-replace-fda-approved-medications-for-alcohol-use-disorder-2837-5789/ 2024-11-30T01:54:48+00:00 https://de.pi-multilingual.rt.gw/section/clozapine-and-ocd-like-symptoms-whats-the-connection-2842-5804/ 2024-12-30T22:02:40+00:00 https://de.pi-multilingual.rt.gw/section/is-valproate-weight-gain-dose-dependent-2842-5805/ 2024-12-30T22:02:40+00:00 https://de.pi-multilingual.rt.gw/section/beyond-antidepressants-dopamine-agonists-for-treatment-resistant-depression-2842-5806/ 2024-12-30T22:10:39+00:00 https://de.pi-multilingual.rt.gw/section/does-delirium-increase-the-risk-of-dementia-2842-5807/ 2024-12-30T22:20:55+00:00 https://de.pi-multilingual.rt.gw/section/new-clinical-guidelines-for-treating-stimulant-use-disorder-2842-5808/ 2024-12-30T22:29:57+00:00 https://de.pi-multilingual.rt.gw/section/perinatal-treatment-overcoming-barriers-and-increasing-confidence-2846-5803/ 2024-12-30T23:08:55+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2846-5816/ 2024-12-31T13:31:55+00:00 https://de.pi-multilingual.rt.gw/section/lithium-in-pregnancy-and-breastfeeding-2846-5811/ 2024-12-31T13:34:45+00:00 https://de.pi-multilingual.rt.gw/section/ssri-treatment-during-pregnancy-a-clinical-case-2846-5812/ 2024-12-31T13:34:46+00:00 https://de.pi-multilingual.rt.gw/section/pregnancy-adhd-and-stimulants-making-an-informed-choice-2846-5814/ 2024-12-31T13:34:46+00:00 https://de.pi-multilingual.rt.gw/section/perinatal-psychiatry-resources-expanding-your-expertise-2846-5815/ 2024-12-31T13:34:46+00:00 https://de.pi-multilingual.rt.gw/section/psychiatric-medications-in-pregnancy-balancing-maternal-and-fetal-well-being-2846-5810/ 2024-12-31T14:03:59+00:00 https://de.pi-multilingual.rt.gw/section/pregnancys-impact-on-medication-efficacy-and-dosing-considerations-2846-5809/ 2025-01-10T20:04:38+00:00 https://de.pi-multilingual.rt.gw/section/valproate-in-pregnancy-key-considerations-2846-5813/ 2025-01-10T20:04:38+00:00 https://de.pi-multilingual.rt.gw/section/pneumonia-in-schizophrenia-which-antipsychotics-pose-the-highest-risk-for-2843-5817/ 2025-01-31T16:06:44+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-induced-weight-gain-best-management-strategies-2843-5818/ 2025-01-31T16:06:44+00:00 https://de.pi-multilingual.rt.gw/section/what-is-the-optimal-therapeutic-range-for-lithium-in-bipolar-disorder-2843-5819/ 2025-01-31T16:06:45+00:00 https://de.pi-multilingual.rt.gw/section/depression-b-vitamins-and-cognition-is-there-a-connection-2843-5820/ 2025-01-31T16:06:45+00:00 https://de.pi-multilingual.rt.gw/section/understanding-canmats-evidence-rating-and-treatment-lines-for-depression-2864-5822/ 2025-02-01T00:10:41+00:00 https://de.pi-multilingual.rt.gw/section/collaborative-decision-making-in-depression-treatment-2864-5823/ 2025-02-01T00:10:41+00:00 https://de.pi-multilingual.rt.gw/section/selecting-the-initial-depression-treatment-2864-5824/ 2025-02-01T00:10:41+00:00 https://de.pi-multilingual.rt.gw/section/complementary-and-alternative-medicine-for-depression-canmat-recommendations-2864-5825/ 2025-02-01T00:10:41+00:00 https://de.pi-multilingual.rt.gw/section/maintenance-treatment-for-depression-prevention-2864-5826/ 2025-02-01T00:10:41+00:00 https://de.pi-multilingual.rt.gw/section/assessing-difficult-to-treat-depression-2864-5827/ 2025-02-01T00:10:42+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-management-of-difficult-to-treat-depression-first-second-and-third-line-options-2864-5828/ 2025-02-01T00:10:42+00:00 https://de.pi-multilingual.rt.gw/section/neurostimulation-strategies-for-managing-difficult-to-treat-depression-2864-5829/ 2025-02-01T00:10:42+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-collaborating-with-patients-to-optimize-treatment-2864-5830/ 2025-02-01T00:10:42+00:00 https://de.pi-multilingual.rt.gw/section/canmat-depression-guidelines-key-takeaways-2864-5831/ 2025-02-01T00:10:42+00:00 https://de.pi-multilingual.rt.gw/section/do-antidepressants-increase-fall-risk-in-older-adults-2847-5834/ 2025-02-27T00:28:40+00:00 https://de.pi-multilingual.rt.gw/section/ketamine-and-esketamine-for-bipolar-depression-2847-5835/ 2025-02-27T00:38:35+00:00 https://de.pi-multilingual.rt.gw/section/can-glp-1-agonists-treat-alcohol-use-disorder-2847-5832/ 2025-02-27T00:50:11+00:00 https://de.pi-multilingual.rt.gw/section/which-antidepressants-cause-the-most-weight-gain-2847-5833/ 2025-02-27T00:50:11+00:00 https://de.pi-multilingual.rt.gw/section/is-aripiprazole-really-metabolically-safer-than-olanzapine-2847-5836/ 2025-02-27T00:50:11+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-induced-weight-gain-prevention-and-management-2880-5839/ 2025-02-27T22:02:51+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-induced-gastrointestinal-issues-sialorrhea-and-constipation-2880-5847/ 2025-02-27T22:26:11+00:00 https://de.pi-multilingual.rt.gw/section/treatment-strategies-for-akathisia-and-parkinsonism-2880-5840/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/recognizing-and-addressing-neuroleptic-malignant-syndrome-and-acute-dystonia-2880-5841/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-induced-tardive-dyskinesia-assessment-and-monitoring-2880-5842/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-antipsychotic-induced-tardive-dyskinesia-2880-5843/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/managing-hyperprolactinemia-and-sexual-side-effects-from-antipsychotic-use-2880-5844/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/addressing-cardiac-side-effects-of-antipsychotic-treatment-2880-5845/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-side-effects-receptor-profiles-overview-2880-5837/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/managing-antipsychotic-induced-sedation-2880-5838/ 2025-02-27T22:29:21+00:00 https://de.pi-multilingual.rt.gw/section/managing-antipsychotic-induced-orthostatic-hypotension-and-seizures-2880-5846/ 2025-02-27T22:29:22+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2880-5848/ 2025-02-27T22:29:22+00:00 https://de.pi-multilingual.rt.gw/section/can-lisdexamfetamine-treat-methamphetamine-use-disorder-2865-5852/ 2025-03-25T01:52:30+00:00 https://de.pi-multilingual.rt.gw/section/alzheimers-disease-olanzapine-vs-risperidone-for-bpsd-2865-5851/ 2025-03-25T23:28:55+00:00 https://de.pi-multilingual.rt.gw/section/chronotherapy-can-circadian-rhythms-impact-treatment-efficacy-2865-5853/ 2025-03-25T23:28:55+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2883-5862/ 2025-03-27T15:43:45+00:00 https://de.pi-multilingual.rt.gw/section/management-of-eating-disorders-overview-clinical-case-2883-5854/ 2025-03-28T00:06:43+00:00 https://de.pi-multilingual.rt.gw/section/bulimia-nervosa-medications-that-work-2883-5855/ 2025-03-28T00:06:43+00:00 https://de.pi-multilingual.rt.gw/section/key-considerations-when-prescribing-for-bulimia-nervosa-2883-5856/ 2025-03-28T00:06:44+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-pharmacotherapy-in-anorexia-nervosa-2883-5857/ 2025-03-28T00:06:44+00:00 https://de.pi-multilingual.rt.gw/section/anorexia-with-mood-symptoms-a-targeted-pharmacologic-approach-2883-5858/ 2025-03-28T00:06:44+00:00 https://de.pi-multilingual.rt.gw/section/binge-eating-disorder-pharmacotherapy-antidepressants-and-anticonvulsants-2883-5859/ 2025-03-28T00:06:44+00:00 https://de.pi-multilingual.rt.gw/section/binge-eating-disorder-pharmacotherapy-lisdexamfetamine-2883-5860/ 2025-03-28T00:06:44+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-treatment-decisions-in-bulimia-nervosa-2883-5861/ 2025-03-28T00:06:44+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-disorder-maintenance-whats-the-optimal-dose-range-2865-5850/ 2025-03-31T20:52:00+00:00 https://de.pi-multilingual.rt.gw/section/introduction-psychopharmacology-algorithms-ptsd-2036-3988/ 2025-04-16T15:58:54+00:00 https://de.pi-multilingual.rt.gw/section/differential-diagnosis-of-ptsd-the-importance-of-comorbidities-2036-3989/ 2025-04-16T15:58:54+00:00 https://de.pi-multilingual.rt.gw/section/sleep-assessment-in-ptsd-is-sleep-disturbed-node-2-2036-3990/ 2025-04-16T15:58:54+00:00 https://de.pi-multilingual.rt.gw/section/prazosin-for-ptsd-related-nightmares-rationale-and-dosing-strategies-for-men-and-women-2036-3991/ 2025-04-16T15:58:54+00:00 https://de.pi-multilingual.rt.gw/section/trazodone-for-disturbed-sleep-initiation-in-ptsd-2036-3992/ 2025-04-16T15:58:54+00:00 https://de.pi-multilingual.rt.gw/section/other-options-for-improving-sleep-latency-in-ptsd-2036-3993/ 2025-04-16T15:58:54+00:00 https://de.pi-multilingual.rt.gw/section/undesirable-initial-choices-for-sleep-management-in-ptsd-2036-3994/ 2025-04-16T15:58:54+00:00 https://de.pi-multilingual.rt.gw/section/assessment-and-management-of-non-sleep-symptoms-using-ssris-node-3-2036-3995/ 2025-04-16T15:58:55+00:00 https://de.pi-multilingual.rt.gw/section/management-of-psychotic-symptoms-in-ptsd-node-3a-2036-3996/ 2025-04-16T15:58:55+00:00 https://de.pi-multilingual.rt.gw/section/management-of-non-response-to-initial-ssri-trial-node-4-2036-3997/ 2025-04-16T15:58:55+00:00 https://de.pi-multilingual.rt.gw/section/management-of-non-response-to-two-ssri-trials-node-5-2036-3998/ 2025-04-16T15:58:55+00:00 https://de.pi-multilingual.rt.gw/section/augmentation-strategies-adding-a-second-drug-node-5a-2036-3999/ 2025-04-16T15:58:55+00:00 https://de.pi-multilingual.rt.gw/section/summary-of-recommendations-2036-4000/ 2025-04-16T15:58:55+00:00 https://de.pi-multilingual.rt.gw/section/epidemiology-update-how-did-we-get-here-2037-4683/ 2025-04-16T16:03:10+00:00 https://de.pi-multilingual.rt.gw/section/diagnosis-how-to-recognize-an-opioid-use-disorder-2037-4684/ 2025-04-16T16:03:10+00:00 https://de.pi-multilingual.rt.gw/section/from-opium-to-heroin-2037-4685/ 2025-04-16T16:03:10+00:00 https://de.pi-multilingual.rt.gw/section/naloxone-for-overdose-prevention-2037-4005/ 2025-04-16T16:03:11+00:00 https://de.pi-multilingual.rt.gw/section/introduction-buprenorphine-2037-4001/ 2025-04-16T16:03:11+00:00 https://de.pi-multilingual.rt.gw/section/buprenorphine-for-opioid-use-disorder-mechanism-of-action-2037-4002/ 2025-04-16T16:03:11+00:00 https://de.pi-multilingual.rt.gw/section/buprenorphine-formulations-a-practical-summary-for-clinicians-2037-4003/ 2025-04-16T16:03:11+00:00 https://de.pi-multilingual.rt.gw/section/buprenorphine-in-non-specialty-settings-2037-4004/ 2025-04-16T16:03:11+00:00 https://de.pi-multilingual.rt.gw/section/prevalence-2038-4006/ 2025-04-16T16:05:54+00:00 https://de.pi-multilingual.rt.gw/section/the-neurobiology-of-behavioral-and-psychological-symptoms-of-dementia-an-illustrated-update-2038-4007/ 2025-04-16T16:05:54+00:00 https://de.pi-multilingual.rt.gw/section/assessment-of-behavioral-and-psychological-symptoms-in-dementia-2038-4008/ 2025-04-16T16:05:54+00:00 https://de.pi-multilingual.rt.gw/section/algorithm-for-the-assessment-of-bpsd-2038-4009/ 2025-04-16T16:05:54+00:00 https://de.pi-multilingual.rt.gw/section/evidence-of-efficacy-non-pharmacological-management-antipsychotics-antidepressants-2038-4010/ 2025-04-16T16:05:54+00:00 https://de.pi-multilingual.rt.gw/section/evidence-of-efficacy-mood-stabilizers-acheis-memantine-and-benzodiazepines-2038-4011/ 2025-04-16T16:05:54+00:00 https://de.pi-multilingual.rt.gw/section/a-simplified-algorithm-for-the-management-of-bpsd-2038-4012/ 2025-04-16T16:05:54+00:00 https://de.pi-multilingual.rt.gw/section/summary-of-the-latest-apa-recommendations-on-the-use-of-antipsychotics-to-treat-agitation-or-psychosis-in-patients-with-dementia-2038-4013/ 2025-04-16T16:05:55+00:00 https://de.pi-multilingual.rt.gw/section/the-mechanism-of-action-of-ssris-2051-4050/ 2025-04-16T16:08:00+00:00 https://de.pi-multilingual.rt.gw/section/the-psychopharmacology-of-fluoxetine-mechanism-of-action-indications-pharmacokinetics-and-dosing-2051-4051/ 2025-04-16T16:08:00+00:00 https://de.pi-multilingual.rt.gw/section/fluvoxamine-essentials-mechanism-of-action-indications-pharmacokinetics-and-dosing-2051-4052/ 2025-04-16T16:08:01+00:00 https://de.pi-multilingual.rt.gw/section/paroxetine-moa-indications-pharmacokinetics-and-dosing-2051-4053/ 2025-04-16T16:08:01+00:00 https://de.pi-multilingual.rt.gw/section/sertraline-moa-indications-pharmacokinetics-and-dosing-2051-4054/ 2025-04-16T16:08:01+00:00 https://de.pi-multilingual.rt.gw/section/citalopram-and-escitalopram-moa-indications-pharmacokinetics-and-dosing-2051-4055/ 2025-04-16T16:08:01+00:00 https://de.pi-multilingual.rt.gw/section/the-psychopharmacology-of-bupropion-an-illustrated-overview-2051-4056/ 2025-04-16T16:08:01+00:00 https://de.pi-multilingual.rt.gw/section/current-medical-use-and-therapeutic-potential-2054-4057/ 2025-04-16T16:18:35+00:00 https://de.pi-multilingual.rt.gw/section/cannabis-use-disorder-propensity-for-addiction-2054-4058/ 2025-04-16T16:18:35+00:00 https://de.pi-multilingual.rt.gw/section/treatment-of-cannabis-use-disorder-2054-4059/ 2025-04-16T16:18:35+00:00 https://de.pi-multilingual.rt.gw/section/phytocannabinoids-cannabis-plant-modes-of-consumption-and-sinsemilla-2054-4060/ 2025-04-16T16:18:35+00:00 https://de.pi-multilingual.rt.gw/section/understanding-cannabis-in-psychiatry-pharmacology-and-synthetic-cannabinoids-2054-4061/ 2025-04-16T16:18:35+00:00 https://de.pi-multilingual.rt.gw/section/cannabis-effects-on-cognition-and-driving-2054-4062/ 2025-04-16T16:18:35+00:00 https://de.pi-multilingual.rt.gw/section/cannabis-use-and-psychiatric-disorders-psychosis-and-anxiety-2054-4063/ 2025-04-16T16:18:35+00:00 https://de.pi-multilingual.rt.gw/section/defining-and-assessing-treatment-resistant-depression-2055-4064/ 2025-04-16T16:22:09+00:00 https://de.pi-multilingual.rt.gw/section/strategies-switching-antidepressants-2055-4065/ 2025-04-16T16:22:09+00:00 https://de.pi-multilingual.rt.gw/section/strategies-combination-and-augmentation-2055-4066/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/combining-antidepressants-2055-4067/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/augmentation-with-second-generation-antipsychotics-2055-4068/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/use-of-mood-stabilizers-in-treatment-resistant-depression-2055-4069/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/use-of-stimulants-and-dopamine-agonists-methylphenidate-amphetamines-and-pramipexole-2055-4070/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/other-augmenting-options-t3-same-folate-and-omega-3-fish-oils-2055-4071/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/psychosocial-interventions-2055-4072/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/inflammation-and-depression-use-of-anti-inflammatory-agents-and-the-role-of-inflammatory-markers-crp-2055-4073/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/experimental-treatments-ketamine-2055-4074/ 2025-04-16T16:22:10+00:00 https://de.pi-multilingual.rt.gw/section/experimental-treatments-psilocybin-2055-4075/ 2025-04-16T16:22:11+00:00 https://de.pi-multilingual.rt.gw/section/neuromodulation-ect-2055-4076/ 2025-04-16T16:22:11+00:00 https://de.pi-multilingual.rt.gw/section/neuromodulation-tms-and-vns-2055-4077/ 2025-04-16T16:22:11+00:00 https://de.pi-multilingual.rt.gw/section/neuromodulation-dbs-2055-4078/ 2025-04-16T16:22:11+00:00 https://de.pi-multilingual.rt.gw/section/a-treatment-algorithm-2055-4079/ 2025-04-16T16:22:11+00:00 https://de.pi-multilingual.rt.gw/section/introduction-the-practice-of-geriatric-psychopharmacology-2056-4080/ 2025-04-16T16:27:14+00:00 https://de.pi-multilingual.rt.gw/section/minimizing-adverse-effects-and-drug-interactions-2056-4081/ 2025-04-16T16:27:14+00:00 https://de.pi-multilingual.rt.gw/section/geriatric-psychopharmacology-how-pharmacokinetic-and-pharmacodynamic-changes-affect-prescribing-2056-4082/ 2025-04-16T16:27:15+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotics-clinical-uses-interactions-drug-selection-and-formulations-2056-4083/ 2025-04-16T16:27:15+00:00 https://de.pi-multilingual.rt.gw/section/adverse-effects-of-antipsychotics-in-elderly-patients-2056-4084/ 2025-04-16T16:27:15+00:00 https://de.pi-multilingual.rt.gw/section/antidepressants-focus-on-geriatric-depression-drug-selection-formulations-and-treatment-resistance-2056-4085/ 2025-04-16T16:27:15+00:00 https://de.pi-multilingual.rt.gw/section/antidepressants-adverse-effects-in-the-elderly-2056-4086/ 2025-04-16T16:27:15+00:00 https://de.pi-multilingual.rt.gw/section/managing-geriatric-bipolar-disorder-use-of-lithium-and-anticonvulsants-2056-4087/ 2025-04-16T16:27:15+00:00 https://de.pi-multilingual.rt.gw/section/use-of-sedative-hypnotic-drugs-in-the-elderly-2056-4088/ 2025-04-16T16:27:15+00:00 https://de.pi-multilingual.rt.gw/section/introduction-2057-4089/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/comorbidities-and-other-features-2057-4090/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/suicidal-behavior-and-clozapine-use-2057-4091/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/hostileaggressive-behavior-2057-4092/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/agitation-requiring-im-antipsychotics-2057-4093/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/management-of-negative-symptoms-2057-4094/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/major-depression-2057-4095/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/node-1-introduction-2057-4100/ 2025-04-16T16:31:02+00:00 https://de.pi-multilingual.rt.gw/section/women-of-childbearing-potential-2057-4096/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/active-substance-use-disorders-2057-4097/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/qtc-prolongation-2057-4098/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/elderly-patients-2057-4099/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/how-to-choose-among-sgas-2057-4101/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/newer-sgas-2057-4102/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/drugs-not-recommended-at-node-1-2057-4103/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/node-1a-intolerance-or-inadequate-trial-of-a-node-1-antipsychotic-2057-4104/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/node-2-unsatisfactory-response-to-an-adequate-trial-of-a-node-1-antipsychotic-2057-4105/ 2025-04-16T16:31:03+00:00 https://de.pi-multilingual.rt.gw/section/assessment-of-acute-agitation-2058-4106/ 2025-04-16T16:33:31+00:00 https://de.pi-multilingual.rt.gw/section/general-principles-treatment-goals-and-drug-selection-2058-4107/ 2025-04-16T16:33:31+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotics-for-agitation-differences-between-tablets-orally-disintegrating-tablets-and-sublingual-formulations-2058-4108/ 2025-04-16T16:33:31+00:00 https://de.pi-multilingual.rt.gw/section/injectable-antipsychotics-formulations-and-practical-strategies-2058-4109/ 2025-04-16T16:33:31+00:00 https://de.pi-multilingual.rt.gw/section/oral-benzodiazepines-2058-4110/ 2025-04-16T16:33:31+00:00 https://de.pi-multilingual.rt.gw/section/injectable-benzodiazepines-focus-on-lorazepam-2058-4111/ 2025-04-16T16:33:32+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-induced-dystonia-diagnosis-and-management-2058-4112/ 2025-04-16T16:33:32+00:00 https://de.pi-multilingual.rt.gw/section/introduction-managing-the-nonhematological-adverse-effects-of-clozapine-2061-4126/ 2025-04-16T16:36:24+00:00 https://de.pi-multilingual.rt.gw/section/clozapine-induced-sialorrhea-why-is-it-important-and-how-should-you-manage-it-2061-4127/ 2025-04-16T16:36:24+00:00 https://de.pi-multilingual.rt.gw/section/managing-clozapine-induced-constipation-practical-advice-2061-4128/ 2025-04-16T16:36:24+00:00 https://de.pi-multilingual.rt.gw/section/managing-orthostasis-2061-4129/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/managing-fever-2061-4130/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/managing-tachycardia-2061-4131/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/myocarditis-and-cardiomyopathy-2061-4132/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/metabolic-effects-2061-4133/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/sedation-2061-4134/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/seizures-2061-4135/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/conclusions-2061-4136/ 2025-04-16T16:36:25+00:00 https://de.pi-multilingual.rt.gw/section/lurasidone-for-bipolar-depression-what-is-the-optimal-dose-2866-5863/ 2025-04-23T16:05:04+00:00 https://de.pi-multilingual.rt.gw/section/alcohol-use-disorder-should-disulfiram-be-first-line-2866-5864/ 2025-04-23T16:05:04+00:00 https://de.pi-multilingual.rt.gw/section/melatonin-trazodone-or-doxepin-for-sleep-disorders-2866-5865/ 2025-04-23T16:05:04+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-qt-warnings-do-they-reflect-true-cardiac-risk-2866-5866/ 2025-04-23T16:05:04+00:00 https://de.pi-multilingual.rt.gw/section/are-we-overvaluing-or-underutilizing-clozapine-in-psychiatry-clozapine-versus-second-generation-antipsychotics-in-treatment-resistant-schizophrenia-2866-5867/ 2025-04-23T16:05:04+00:00 https://de.pi-multilingual.rt.gw/section/baseline-testing-monitoring-and-optimal-dosing-of-lithium-2889-5869/ 2025-04-29T21:32:46+00:00 https://de.pi-multilingual.rt.gw/section/managing-renal-side-effects-of-lithium-therapy-2889-5870/ 2025-04-29T21:32:46+00:00 https://de.pi-multilingual.rt.gw/section/how-to-mitigate-weight-gain-and-gastrointestinal-side-effects-of-lithium-2889-5871/ 2025-04-29T21:32:46+00:00 https://de.pi-multilingual.rt.gw/section/managing-thyroid-and-parathyroid-dysfunction-with-lithium-2889-5872/ 2025-04-29T21:32:46+00:00 https://de.pi-multilingual.rt.gw/section/addressing-cognitive-impairment-and-tremor-with-lithium-2889-5873/ 2025-04-29T21:32:46+00:00 https://de.pi-multilingual.rt.gw/section/approaching-sexual-dysfunction-hair-loss-and-rashes-with-lithium-2889-5874/ 2025-04-29T21:32:46+00:00 https://de.pi-multilingual.rt.gw/section/case-lithium-in-the-management-of-a-complex-patient-with-bipolar-disorder-2889-5875/ 2025-04-29T21:32:46+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2889-5876/ 2025-04-29T21:32:47+00:00 https://de.pi-multilingual.rt.gw/section/introduction-and-how-to-persuade-patients-to-take-lithium-2889-5868/ 2025-05-13T16:09:26+00:00 https://de.pi-multilingual.rt.gw/section/schizophrenia-algorithm-selecting-an-antipsychotic-for-first-episodes-2867-5877/ 2025-05-28T02:30:03+00:00 https://de.pi-multilingual.rt.gw/section/do-ssri-side-effects-improve-over-time-2867-5878/ 2025-05-28T02:30:03+00:00 https://de.pi-multilingual.rt.gw/section/torsades-de-pointes-impact-of-antidepressants-and-antipsychotics-2867-5879/ 2025-05-28T02:30:03+00:00 https://de.pi-multilingual.rt.gw/section/are-psychedelics-effective-for-treating-substance-use-disorders-2867-5880/ 2025-05-28T02:45:49+00:00 https://de.pi-multilingual.rt.gw/section/the-neuroscience-behind-teas-effects-on-mental-health-2867-5881/ 2025-05-28T02:57:50+00:00 https://de.pi-multilingual.rt.gw/section/the-role-of-long-acting-injectable-antipsychotics-in-schizophrenia-treatment-2881-5882/ 2025-05-28T17:35:37+00:00 https://de.pi-multilingual.rt.gw/section/understanding-when-to-prescribe-lais-2881-5883/ 2025-05-30T16:07:34+00:00 https://de.pi-multilingual.rt.gw/section/why-choose-lais-benefits-in-schizophrenia-2881-5884/ 2025-05-30T16:18:24+00:00 https://de.pi-multilingual.rt.gw/section/balancing-risks-challenges-of-lai-treatment-2881-5885/ 2025-05-30T16:18:24+00:00 https://de.pi-multilingual.rt.gw/section/guiding-the-conversation-how-to-discuss-lais-with-patients-2881-5886/ 2025-05-30T16:18:24+00:00 https://de.pi-multilingual.rt.gw/section/lais-in-practice-haloperidol-and-fluphenazine-2881-5887/ 2025-05-30T16:18:24+00:00 https://de.pi-multilingual.rt.gw/section/lais-in-practice-aripiprazole-olanzapine-2881-5888/ 2025-05-30T16:18:24+00:00 https://de.pi-multilingual.rt.gw/section/lais-in-practice-paliperidone-risperidone-2881-5889/ 2025-05-30T16:18:24+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-2881-5890/ 2025-05-30T16:18:25+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2881-5891/ 2025-05-30T16:18:25+00:00 https://de.pi-multilingual.rt.gw/section/understanding-lamotrigine-mechanisms-and-titration-schedule-2791-5634/ 2025-06-20T19:07:51+00:00 https://de.pi-multilingual.rt.gw/section/understanding-catatonia-terminology-and-subtypes-2911-5897/ 2025-06-30T19:39:50+00:00 https://de.pi-multilingual.rt.gw/section/catatonia-diagnosis-assessment-tips-2911-5898/ 2025-06-30T19:39:50+00:00 https://de.pi-multilingual.rt.gw/section/catatonia-diagnosis-the-lorazepam-challenge-2911-5899/ 2025-06-30T19:39:50+00:00 https://de.pi-multilingual.rt.gw/section/differential-diagnosis-and-identifying-underlying-causes-of-catatonia-2911-5900/ 2025-06-30T19:39:50+00:00 https://de.pi-multilingual.rt.gw/section/medical-complications-and-prognostic-considerations-in-catatonia-2911-5901/ 2025-06-30T19:39:50+00:00 https://de.pi-multilingual.rt.gw/section/catatonia-pharmacotherapy-the-role-of-benzodiazepines-2911-5902/ 2025-06-30T19:39:51+00:00 https://de.pi-multilingual.rt.gw/section/neuromodulation-therapies-ect-and-rtms-in-catatonia-2911-5903/ 2025-06-30T19:39:51+00:00 https://de.pi-multilingual.rt.gw/section/nmda-antagonists-for-catatonia-management-amantadine-memantine-and-ketamine-2911-5904/ 2025-06-30T19:39:51+00:00 https://de.pi-multilingual.rt.gw/section/other-pharmacologic-strategies-for-catatonia-zolpidem-bromocriptine-and-cariprazine-2911-5905/ 2025-06-30T19:39:51+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-2911-5906/ 2025-06-30T19:39:51+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2911-5907/ 2025-06-30T19:39:51+00:00 https://de.pi-multilingual.rt.gw/section/lumateperone-for-depression-with-mixed-features-is-it-effective-2874-5892/ 2025-07-01T00:11:25+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-induced-weight-gain-are-glp-1-agonists-effective-2874-5893/ 2025-07-01T00:11:25+00:00 https://de.pi-multilingual.rt.gw/section/treatment-resistant-depression-lithium-vs-quetiapine-for-augmentation-2874-5894/ 2025-07-01T00:11:25+00:00 https://de.pi-multilingual.rt.gw/section/do-antidepressants-worsen-cognition-in-patients-with-dementia-2874-5895/ 2025-07-01T00:11:25+00:00 https://de.pi-multilingual.rt.gw/section/probiotics-and-prebiotics-for-depression-and-anxiety-can-the-gut-heal-the-mind-2874-5896/ 2025-07-01T00:11:25+00:00 https://de.pi-multilingual.rt.gw/section/alcohol-use-disorder-algorithm-medication-selection-based-on-liver-status-2892-5918/ 2025-07-25T04:59:59+00:00 https://de.pi-multilingual.rt.gw/section/aud-with-respiratory-and-infectious-comorbidities-medication-adjustments-2892-5919/ 2025-07-25T04:59:59+00:00 https://de.pi-multilingual.rt.gw/section/managing-aud-in-patients-with-co-occurring-cardiovascular-and-renal-disease-2892-5920/ 2025-07-25T04:59:59+00:00 https://de.pi-multilingual.rt.gw/section/clinical-vignette-2892-5921/ 2025-07-25T04:59:59+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2892-5922/ 2025-07-25T05:00:00+00:00 https://de.pi-multilingual.rt.gw/section/long-acting-injectables-superior-for-reducing-mortality-in-schizophrenia-2865-5849/ 2025-08-30T22:20:59+00:00 https://de.pi-multilingual.rt.gw/section/treatment-resistant-bipolar-depression-is-adjunctive-pramipexole-an-option/ 2025-08-30T23:06:25+00:00 https://de.pi-multilingual.rt.gw/section/does-semaglutide-reverse-clozapine-induced-weight-gain-in-schizophrenia-results-from-the-coast-trial/ 2025-08-30T23:18:14+00:00 https://de.pi-multilingual.rt.gw/section/cannabis-induced-psychosis-which-antipsychotics-best-prevent-hospitalization/ 2025-08-31T00:10:14+00:00 https://de.pi-multilingual.rt.gw/section/treatment-resistant-depression-which-treatments-are-most-effective-a-network-meta-analysis/ 2025-08-31T00:28:14+00:00 https://de.pi-multilingual.rt.gw/section/is-gut-microbiota-altered-in-depression-and-anxiety/ 2025-08-31T00:46:02+00:00 https://de.pi-multilingual.rt.gw/section/naltrexone-for-alcohol-use-disorder-dosing-monitoring-and-liver-safety/ 2025-08-31T00:48:21+00:00 https://de.pi-multilingual.rt.gw/section/acamprosate-in-alcohol-use-disorder-mechanism-of-action-dosing-efficacy-and-safety/ 2025-08-31T00:48:31+00:00 https://de.pi-multilingual.rt.gw/section/disulfiram-for-alcohol-use-disorder-mechanisms-efficacy-and-hepatic-safety-considerations/ 2025-08-31T00:48:40+00:00 https://de.pi-multilingual.rt.gw/section/gabapentin-topiramate-and-baclofen-for-alcohol-use-disorder/ 2025-08-31T00:49:03+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages/ 2025-09-01T02:47:22+00:00 https://de.pi-multilingual.rt.gw/section/neurobiological-mechanisms-of-antidepressant-withdrawal/ 2025-09-01T02:53:48+00:00 https://de.pi-multilingual.rt.gw/section/hyperbolic-tapering-of-antidepressants-neurobiological-basis/ 2025-09-01T02:55:42+00:00 https://de.pi-multilingual.rt.gw/section/hyperbolic-tapering-of-antidepressants-clinical-evidence/ 2025-09-01T02:56:18+00:00 https://de.pi-multilingual.rt.gw/section/clinical-cases/ 2025-09-01T02:57:58+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-deprescribing-clinical-rationale-and-common-barriers/ 2025-09-01T15:21:04+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-withdrawal-diagnosis-distinguishing-from-relapse/ 2025-09-05T12:46:26+00:00 https://de.pi-multilingual.rt.gw/section/implementing-hyperbolic-antidepressant-tapering-formulation-options-and-clinical-considerations/ 2025-09-05T12:47:25+00:00 https://de.pi-multilingual.rt.gw/section/deprescribing-ssris-and-mirtazapine-hyperbolic-tapering-techniques/ 2025-09-05T12:48:17+00:00 https://de.pi-multilingual.rt.gw/section/deprescribing-snris-hyperbolic-tapering-techniques/ 2025-09-05T12:49:24+00:00 https://de.pi-multilingual.rt.gw/section/current-trends-in-antidepressant-use-and-withdrawal-guidelines/ 2025-09-08T12:09:13+00:00 https://de.pi-multilingual.rt.gw/section/exploring-the-world-of-psychedelics-an-introduction-2813-5747/ 2025-09-09T03:00:16+00:00 https://de.pi-multilingual.rt.gw/section/pharmacotherapy-for-alcohol-use-disorder-evidence-efficacy-and-treatment-gaps/ 2025-09-11T23:24:01+00:00 https://de.pi-multilingual.rt.gw/section/intermittent-selective-serotonin-reuptake-inhibitors-for-premenstrual-syndromes-a-systematic-review-and-meta-analysis-of-randomized-trials-2693-5370/ 2025-09-12T17:59:04+00:00 https://de.pi-multilingual.rt.gw/section/a-novel-brief-fully-automated-intervention-to-extend-the-antidepressant-effect-of-a-single-ketamine-infusion-a-randomized-clinical-trial-2693-5366/ 2025-09-12T18:01:04+00:00 https://de.pi-multilingual.rt.gw/section/neurologic-and-psychiatric-risk-trajectories-after-sars-cov-2-infection-an-analysis-of-2-year-retrospective-cohort-studies-including-1284437-patients-2693-5367/ 2025-09-12T18:02:51+00:00 https://de.pi-multilingual.rt.gw/section/mdma-assisted-psychotherapy-for-posttraumatic-stress-disorder-the-devil-is-in-the-detail-2693-5368/ 2025-09-12T18:04:04+00:00 https://de.pi-multilingual.rt.gw/section/association-of-antidepressant-use-during-pregnancy-with-risk-of-neurodevelopmental-disorders-in-children-2693-5369/ 2025-09-12T18:05:28+00:00 https://de.pi-multilingual.rt.gw/section/integrate-new-schizophrenia-treatment-guidelines/ 2025-09-17T01:52:13+00:00 https://de.pi-multilingual.rt.gw/section/is-lurasidone-effective-for-bipolar-depression-with-comorbid-anxiety/ 2025-09-17T01:58:03+00:00 https://de.pi-multilingual.rt.gw/section/do-ssris-increase-major-bleeding-risk-with-oral-anticoagulants/ 2025-09-17T02:03:19+00:00 https://de.pi-multilingual.rt.gw/section/new-somatic-treatments-for-child-and-adolescent-depression-part-2-2578-5018/ 2025-09-19T22:46:38+00:00 https://de.pi-multilingual.rt.gw/section/a-method-for-tapering-antipsychotic-treatment-that-may-minimize-the-risk-of-relapse-2603-5064/ 2025-09-19T22:50:02+00:00 https://de.pi-multilingual.rt.gw/section/a-double-blind-placebo-controlled-study-of-brexpiprazole-for-the-treatment-of-borderline-personality-disorder-2658-5232/ 2025-09-19T23:04:48+00:00 https://de.pi-multilingual.rt.gw/section/association-between-physical-activity-and-risk-of-depression-a-systematic-review-and-meta-analysis-2670-5264/ 2025-09-19T23:07:53+00:00 https://de.pi-multilingual.rt.gw/section/an-international-adult-guideline-for-making-clozapine-titration-safer-by-using-6-ancestry-based-personalized-dosing-titrations-crp-and-clozapine-levels-2683-5266/ 2025-09-19T23:10:04+00:00 https://de.pi-multilingual.rt.gw/section/misuse-of-anticholinergic-medications-a-systematic-review-2683-5267/ 2025-09-19T23:12:17+00:00 https://de.pi-multilingual.rt.gw/section/optimal-doses-of-specific-antipsychotics-for-relapse-prevention-in-a-nationwide-cohort-of-patients-with-schizophrenia-2683-5268/ 2025-09-19T23:14:44+00:00 https://de.pi-multilingual.rt.gw/section/metformin-for-the-prevention-of-clozapine-induced-weight-gain-a-retrospective-naturalistic-cohort-study-2683-5269/ 2025-09-19T23:17:15+00:00 https://de.pi-multilingual.rt.gw/section/the-serotonin-theory-of-depression-a-systematic-umbrella-review-of-the-evidence-2683-5270/ 2025-09-19T23:19:09+00:00 https://de.pi-multilingual.rt.gw/section/association-between-olanzapine-concentration-and-metabolic-dysfunction-in-drug-naive-and-chronic-patients-similarities-and-differences-2684-5302/ 2025-09-19T23:21:22+00:00 https://de.pi-multilingual.rt.gw/section/antidepressants-and-vertebral-and-hip-risk-fracture-an-updated-systematic-review-and-meta-analysis-2684-5303/ 2025-09-19T23:22:53+00:00 https://de.pi-multilingual.rt.gw/section/symptomatic-vs-disease-modifying-effects-of-psychiatric-drugs-2684-5304/ 2025-09-19T23:24:47+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-and-dietary-supplement-treatments-for-autism-spectrum-disorder-a-systematic-review-and-network-meta-analysis-2684-5305/ 2025-09-19T23:26:52+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-of-bright-light-therapy-in-perinatal-depression-a-randomized-double-blind-placebo-controlled-study-2684-5306/ 2025-09-19T23:28:28+00:00 https://de.pi-multilingual.rt.gw/section/comparison-of-the-efficacy-and-safety-of-quetiapine-and-lithium-for-bipolar-depression-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials-2685-5323/ 2025-09-19T23:30:00+00:00 https://de.pi-multilingual.rt.gw/section/impact-of-selected-initial-titration-schedules-on-safety-and-long-term-effectiveness-of-lamotrigine-for-the-treatment-of-mood-disorders-2685-5324/ 2025-09-19T23:33:59+00:00 https://de.pi-multilingual.rt.gw/section/the-clinical-effectiveness-of-sertraline-in-primary-care-and-the-role-of-depression-severity-and-duration-panda-a-pragmatic-double-blind-placebo-controlled-randomized-trial-part-1-2685-5325/ 2025-09-19T23:35:15+00:00 https://de.pi-multilingual.rt.gw/section/estimates-of-the-minimal-important-difference-to-evaluate-the-clinical-significance-of-antidepressants-in-the-acute-treatment-of-moderate-to-severe-depression-part-2-2685-5326/ 2025-09-19T23:39:36+00:00 https://de.pi-multilingual.rt.gw/section/omega-3-polyunsaturated-fatty-acids-supplementation-alleviate-anxiety-rather-than-depressive-symptoms-among-first-diagnosed-drug-naive-major-depressive-disorder-patients-a-randomized-clinical-trial-26/ 2025-09-19T23:40:53+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-and-lithium-combination-for-treatment-of-rapid-cycling-bipolar-disorder-results-from-meta-analysis-2692-5349/ 2025-09-29T20:21:29+00:00 https://de.pi-multilingual.rt.gw/section/microdosing-with-psilocybin-mushrooms-a-double-blind-placebo-controlled-study-2692-5350/ 2025-09-29T20:31:11+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-acceptability-of-second-generation-antipsychotics-with-antidepressants-in-unipolar-depression-augmentation-a-systematic-review-and-network-meta-analysis-2692-5351/ 2025-09-29T20:33:48+00:00 https://de.pi-multilingual.rt.gw/section/real-world-effectiveness-of-mood-stabilizer-use-in-schizophrenia-2692-5352/ 2025-09-29T20:46:02+00:00 https://de.pi-multilingual.rt.gw/section/a-systematic-review-of-modified-electroconvulsive-therapy-ect-to-treat-delirium-2692-5353/ 2025-09-29T20:48:14+00:00 https://de.pi-multilingual.rt.gw/section/antipsychotic-augmentation-with-n-acetylcysteine-for-patients-with-schizophrenia-2705-5387/ 2025-09-29T20:57:27+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-safety-of-ketamine-vs-electroconvulsive-therapy-among-patients-with-major-depressive-episode-a-systematic-review-and-meta-analysis-2705-5388/ 2025-09-29T20:59:39+00:00 https://de.pi-multilingual.rt.gw/section/bridging-knowledge-gaps-in-the-diagnosis-and-management-of-neuropsychiatric-sequelae-of-covid-19-2705-5389/ 2025-09-29T21:03:13+00:00 https://de.pi-multilingual.rt.gw/section/sublingual-dexmedetomidine-for-the-treatment-of-acute-agitation-in-adults-with-schizophrenia-or-schizoaffective-disorder-a-randomized-placebo-controlled-trial-2705-5390/ 2025-09-29T21:05:37+00:00 https://de.pi-multilingual.rt.gw/section/naltrexonebupropion-and-behavior-therapy-alone-and-combined-for-binge-eating-disorder-randomized-double-blind-placebo-controlled-trial-2705-5391/ 2025-09-29T21:08:29+00:00 https://de.pi-multilingual.rt.gw/section/haloperidol-for-the-treatment-of-delirium-in-icu-patients-2708-5450/ 2025-09-29T22:26:51+00:00 https://de.pi-multilingual.rt.gw/section/use-of-nsaids-for-delirium-risk-reduction-2738-5542/ 2025-09-29T22:30:41+00:00 https://de.pi-multilingual.rt.gw/section/neonatal-and-pregnancy-complications-following-maternal-depression-or-antidepressant-exposure-2775-5571/ 2025-09-29T22:33:41+00:00 https://de.pi-multilingual.rt.gw/section/the-antidepressant-effects-of-exercise-a-proposed-framework-2843-5821/ 2025-09-29T22:43:02+00:00 https://de.pi-multilingual.rt.gw/section/safety-and-efficacy-of-agomelatine-in-children-and-adolescents-with-major-depressive-disorder-2740-5282/ 2025-09-29T22:49:34+00:00 https://de.pi-multilingual.rt.gw/section/the-knowns-and-unknowns-of-ssri-treatment-in-young-people-with-depression-and-anxiety-2740-5283/ 2025-09-29T22:51:18+00:00 https://de.pi-multilingual.rt.gw/section/long-term-treatment-with-extended-release-methylphenidate-treatment-in-younger-children-2740-5284/ 2025-09-29T23:01:46+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-safety-of-sgas-in-youth-with-bipolar-depression-2740-5285/ 2025-09-29T23:07:31+00:00 https://de.pi-multilingual.rt.gw/section/factors-associated-with-stimulant-treatment-outcomes-in-adhd-2740-5286/ 2025-09-29T23:09:58+00:00 https://de.pi-multilingual.rt.gw/section/depression-in-adolescents-2741-5287/ 2025-09-29T23:12:12+00:00 https://de.pi-multilingual.rt.gw/section/deutetrabenazine-for-children-and-adolescents-with-tourette-syndrome-2741-5288/ 2025-09-29T23:15:31+00:00 https://de.pi-multilingual.rt.gw/section/vortioxetine-for-mdd-in-adolescents-2741-5289/ 2025-09-29T23:18:27+00:00 https://de.pi-multilingual.rt.gw/section/ssris-and-risk-of-type-2-diabetes-in-children-and-adolescents-2741-5290/ 2025-09-29T23:21:47+00:00 https://de.pi-multilingual.rt.gw/section/oxytocin-in-children-and-adolescents-with-asd-2741-5291/ 2025-09-29T23:23:38+00:00 https://de.pi-multilingual.rt.gw/section/do-neurotherapeutics-work-for-adhd-2742-5292/ 2025-09-29T23:25:30+00:00 https://de.pi-multilingual.rt.gw/section/association-of-lithium-and-sgas-with-neurocognition-in-youth-with-bipolar-disorder-2742-5293/ 2025-09-29T23:27:21+00:00 https://de.pi-multilingual.rt.gw/section/early-antipsychotic-nonresponse-as-a-predictor-of-nonresponse-in-adolescents-with-psychosis-2742-5294/ 2025-09-29T23:33:54+00:00 https://de.pi-multilingual.rt.gw/section/effects-of-methylphenidate-on-neurocognitive-functioning-in-children-with-adhd-2742-5295/ 2025-09-29T23:36:20+00:00 https://de.pi-multilingual.rt.gw/section/impact-of-pharmacotherapy-of-childhood-onset-psychiatric-disorders-on-the-development-of-substance-use-disorders-2742-5296/ 2025-09-29T23:38:36+00:00 https://de.pi-multilingual.rt.gw/section/treatment-outcomes-in-youth-with-comorbid-ocd-and-asd-2743-5297/ 2025-09-29T23:40:59+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-safety-of-duloxetine-in-children-and-adolescents-with-mdd-in-japan-2743-5298/ 2025-09-29T23:43:43+00:00 https://de.pi-multilingual.rt.gw/section/maternal-postnatal-depression-and-anxiety-and-the-risk-for-mental-health-disorders-in-adolescent-offspring-2743-5299/ 2025-09-29T23:45:34+00:00 https://de.pi-multilingual.rt.gw/section/long-term-effects-of-lithium-use-on-children-and-adolescents-2743-5300/ 2025-09-29T23:47:11+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-treatment-of-comorbid-adhd-tourette-syndrome-and-tic-disorders-2743-5301/ 2025-09-29T23:48:48+00:00 https://de.pi-multilingual.rt.gw/section/pharmacotherapy-of-adhd-and-comorbid-asd-2744-5318/ 2025-09-29T23:51:16+00:00 https://de.pi-multilingual.rt.gw/section/low-dose-olanzapine-for-treating-adolescents-with-anorexia-nervosa-2744-5319/ 2025-09-29T23:53:35+00:00 https://de.pi-multilingual.rt.gw/section/nacetylcysteine-for-treating-pediatric-mania-and-hypomania-2744-5320/ 2025-09-29T23:55:47+00:00 https://de.pi-multilingual.rt.gw/section/psychotropic-drugs-for-treating-nonsuicidal-selfinjury-in-the-youth-2744-5321/ 2025-09-29T23:57:48+00:00 https://de.pi-multilingual.rt.gw/section/psychopharmacology-in-the-pediatric-oncology-units-2744-5322/ 2025-09-30T00:00:31+00:00 https://de.pi-multilingual.rt.gw/section/understanding-menopause-clinical-definitions-and-symptom-overview/ 2025-09-30T18:34:10+00:00 https://de.pi-multilingual.rt.gw/section/perimenopausal-depression-clinical-presentation-and-neurobiological-mechanisms/ 2025-09-30T18:38:04+00:00 https://de.pi-multilingual.rt.gw/section/identifying-risk-factors-for-perimenopausal-depression/ 2025-09-30T18:39:07+00:00 https://de.pi-multilingual.rt.gw/section/antidepressants-for-perimenopausal-depression/ 2025-09-30T18:40:28+00:00 https://de.pi-multilingual.rt.gw/section/menopausal-hormone-therapy-mht-for-perimenopausal-depression/ 2025-09-30T18:41:54+00:00 https://de.pi-multilingual.rt.gw/section/managing-the-vasomotor-symptoms-vns-of-menopause-evidence-for-ssris-snris-and-cbt/ 2025-09-30T18:46:06+00:00 https://de.pi-multilingual.rt.gw/section/perimenopausal-anxiety-distinguishing-hot-flashes-from-panic-attacks-and-the-role-of-allopregnanolone/ 2025-09-30T19:43:06+00:00 https://de.pi-multilingual.rt.gw/section/perimenopausal-anxiety-pharmacologic-management/ 2025-09-30T19:45:15+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-2/ 2025-09-30T19:46:07+00:00 https://de.pi-multilingual.rt.gw/section/new-guidelines-for-clozapine-anc-monitoring/ 2025-10-02T22:09:40+00:00 https://de.pi-multilingual.rt.gw/section/cariprazine-dosing-for-bipolar-disorder-in-older-adults/ 2025-10-02T22:24:20+00:00 https://de.pi-multilingual.rt.gw/section/semaglutide-for-alcohol-use-disorder-new-rct-data/ 2025-10-03T02:35:42+00:00 https://de.pi-multilingual.rt.gw/section/geriatric-depression-optimizing-strategies-and-common-challenges/ 2025-10-03T02:50:06+00:00 https://de.pi-multilingual.rt.gw/section/is-saffron-as-effective-as-ssris-for-depression-and-anxiety-new-meta-analysis/ 2025-10-03T03:07:19+00:00 https://de.pi-multilingual.rt.gw/section/adhd-medications-and-sleep-2745-5371/ 2025-10-09T22:57:58+00:00 https://de.pi-multilingual.rt.gw/section/treating-pediatric-bipolar-disorder-with-comorbid-conduct-disorder-2745-5372/ 2025-10-09T22:59:28+00:00 https://de.pi-multilingual.rt.gw/section/barriers-to-metabolic-monitoring-of-sgas-in-youth-2745-5373/ 2025-10-09T23:00:44+00:00 https://de.pi-multilingual.rt.gw/section/nonstimulant-treatments-for-adhd-2745-5374/ 2025-10-09T23:02:52+00:00 https://de.pi-multilingual.rt.gw/section/long-term-outcomes-of-behavioral-therapy-for-youth-with-tourette-disorder-2745-5375/ 2025-10-09T23:04:48+00:00 https://de.pi-multilingual.rt.gw/section/pharmacologic-and-nonpharmacologic-interventions-for-persistent-irritability-2746-5392/ 2025-10-09T23:06:15+00:00 https://de.pi-multilingual.rt.gw/section/viloxazine-effect-on-learning-and-school-problems-in-youth-with-adhd-2746-5393/ 2025-10-09T23:07:53+00:00 https://de.pi-multilingual.rt.gw/section/psychotropic-prescriptions-in-youth-during-covid-19-pandemic-2746-5394/ 2025-10-09T23:09:19+00:00 https://de.pi-multilingual.rt.gw/section/efficacy-and-safety-of-lisdexamfetamine-in-preschool-children-with-adhd-2746-5395/ 2025-10-09T23:11:05+00:00 https://de.pi-multilingual.rt.gw/section/a-web-based-pediatric-drug-information-system-to-prevent-serious-adverse-drug-reactions-2746-5396/ 2025-10-09T23:14:09+00:00 https://de.pi-multilingual.rt.gw/section/impact-of-adhd-medications-on-anxiety-and-depression-in-youth-2747-5403/ 2025-10-09T23:16:14+00:00 https://de.pi-multilingual.rt.gw/section/sertraline-in-patients-with-cardiovascular-disease-what-psychiatrists-should-know/ 2025-10-15T16:23:54+00:00 https://de.pi-multilingual.rt.gw/section/does-high-salt-intake-increase-risk-for-depression-and-anxiety/ 2025-10-15T16:24:29+00:00 https://de.pi-multilingual.rt.gw/section/bright-light-therapy-for-bipolar-depression-isbd-clinical-recommendations/ 2025-10-23T00:27:30+00:00 https://de.pi-multilingual.rt.gw/section/varenicline-and-bupropion-effective-for-treating-alcohol-use-disorder/ 2025-10-23T00:49:15+00:00 https://de.pi-multilingual.rt.gw/section/does-ashwagandha-extract-improve-cognitive-function-in-mild-cognitive-impairment/ 2025-10-23T00:56:46+00:00 https://de.pi-multilingual.rt.gw/section/iv-haloperidol-are-cardiac-safety-concerns-overblown/ 2025-10-27T23:35:51+00:00 https://de.pi-multilingual.rt.gw/section/how-effective-is-karxt-xanomeline-trospium-for-schizophrenia-nnt-and-nnh-explained/ 2025-10-29T15:07:16+00:00 https://de.pi-multilingual.rt.gw/section/trends-in-psychotropic-medication-use-among-older-adults/ 2025-11-05T01:50:40+00:00 https://de.pi-multilingual.rt.gw/section/age-related-pharmacological-changes-considerations-for-older-adults/ 2025-11-05T01:56:22+00:00 https://de.pi-multilingual.rt.gw/section/challenges-in-prescribing-psychotropics-in-the-geriatric-population/ 2025-11-05T01:59:34+00:00 https://de.pi-multilingual.rt.gw/section/prescribing-mirtazapine-bupropion-tcas-and-maois-in-the-geriatric-population/ 2025-11-05T02:09:38+00:00 https://de.pi-multilingual.rt.gw/section/augmentation-strategies-and-ect-in-geriatric-depression/ 2025-11-05T02:13:39+00:00 https://de.pi-multilingual.rt.gw/section/mood-stabilizers-in-older-adults-lithium-valproic-acid-and-alternative-agents/ 2025-11-05T02:18:08+00:00 https://de.pi-multilingual.rt.gw/section/benzodiazepines-and-bras-in-older-adults-clinical-considerations/ 2025-11-05T02:27:39+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-3/ 2025-11-05T02:37:08+00:00 https://de.pi-multilingual.rt.gw/section/ssri-and-snri-considerations-for-older-adults-dosing-side-effects-and-monitoring/ 2025-11-07T23:18:28+00:00 https://de.pi-multilingual.rt.gw/section/prescribing-antipsychotics-in-older-adults-clinical-considerations/ 2025-11-07T23:19:41+00:00 https://de.pi-multilingual.rt.gw/section/dementia-pharmacotherapy-from-cholinesterase-inhibitors-to-anti-amyloid-therapies/ 2025-11-07T23:21:21+00:00 https://de.pi-multilingual.rt.gw/section/is-ondansetron-effective-for-negative-symptoms-in-schizophrenia/ 2025-12-01T15:02:01+00:00 https://de.pi-multilingual.rt.gw/section/can-we-predict-who-responds-to-mood-stabilizers/ 2025-12-01T15:08:21+00:00 https://de.pi-multilingual.rt.gw/section/is-ssri-augmentation-superior-to-dose-optimization/ 2025-12-01T15:11:29+00:00 https://de.pi-multilingual.rt.gw/section/is-trazodone-safe-for-insomnia-in-patients-with-alcohol-use-disorder/ 2025-12-01T15:18:44+00:00 https://de.pi-multilingual.rt.gw/section/introduction-to-drug-induced-movement-disorders/ 2025-12-02T21:16:17+00:00 https://de.pi-multilingual.rt.gw/section/akathisia-how-to-diagnose-and-manage/ 2025-12-02T21:16:30+00:00 https://de.pi-multilingual.rt.gw/section/extrapyramidal-symptoms-assessment-tips/ 2025-12-02T21:16:47+00:00 https://de.pi-multilingual.rt.gw/section/psychotropic-induced-tremors-diagnosis-and-management/ 2025-12-02T21:17:18+00:00 https://de.pi-multilingual.rt.gw/section/extrapyramidal-symptoms-medication-and-patient-risk-factors/ 2025-12-02T21:17:40+00:00 https://de.pi-multilingual.rt.gw/section/extrapyramidal-symptoms-management-strategies/ 2025-12-02T21:18:00+00:00 https://de.pi-multilingual.rt.gw/section/tardive-dyskinesia-clinical-features-epidemiology-and-mechanisms/ 2025-12-02T21:18:33+00:00 https://de.pi-multilingual.rt.gw/section/tardive-dyskinesia-treatment-hierarchy/ 2025-12-02T21:18:50+00:00 https://de.pi-multilingual.rt.gw/section/understanding-neurocognitive-side-effects-of-psychotropics-medications/ 2025-12-02T21:19:02+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-4/ 2025-12-02T21:19:16+00:00 https://de.pi-multilingual.rt.gw/section/switching-oral-antipsychotics-six-strategies-and-tips/ 2025-12-31T17:29:02+00:00 https://de.pi-multilingual.rt.gw/section/deprescribing-antipsychotics-post-delirium-why-it-matters/ 2025-12-31T17:40:56+00:00 https://de.pi-multilingual.rt.gw/section/xylazine-tranq-dope-overdose-what-clinicians-should-know/ 2025-12-31T17:58:21+00:00 https://de.pi-multilingual.rt.gw/section/is-pramipexole-effective-for-treatment-resistant-depression/ 2025-12-31T18:13:10+00:00 https://de.pi-multilingual.rt.gw/section/lithium-orotate-breakthrough-treatment-for-alzheimers-disease/ 2025-12-31T18:14:23+00:00 https://de.pi-multilingual.rt.gw/section/are-generic-drugs-truly-interchangeable-with-originals/ 2025-12-31T18:26:12+00:00 https://de.pi-multilingual.rt.gw/section/assessing-bipolar-depression-lab-tests-mood-charts-and-temperament-scales/ 2025-12-31T19:19:51+00:00 https://de.pi-multilingual.rt.gw/section/mixed-bipolar-depression-clinical-features-and-treatment-strategies/ 2025-12-31T19:27:23+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-depression-inflammatory-type/ 2025-12-31T19:31:03+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-depression-vascular-type/ 2025-12-31T19:35:00+00:00 https://de.pi-multilingual.rt.gw/section/lithium-for-bipolar-depression/ 2025-12-31T19:37:55+00:00 https://de.pi-multilingual.rt.gw/section/lamotrigine-for-bipolar-depression/ 2025-12-31T20:08:25+00:00 https://de.pi-multilingual.rt.gw/section/second-generation-antipsychotics-for-bipolar-depression/ 2025-12-31T20:11:11+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-disorder-subtypes-classic-vs-atypical-presentations/ 2025-12-31T20:19:51+00:00 https://de.pi-multilingual.rt.gw/section/bipolar-disorder-subtypes-classic-vs-atypical-presentations-2/ 2025-12-31T20:52:14+00:00 https://de.pi-multilingual.rt.gw/section/adjunctive-treatments-for-bipolar-depression-pramipexole-t3-and-light-therapy/ 2025-12-31T20:52:29+00:00 https://de.pi-multilingual.rt.gw/section/modafinil-omega-3-and-other-third-line-options-for-bipolar-depression/ 2025-12-31T20:55:47+00:00 https://de.pi-multilingual.rt.gw/section/ketamine-tms-and-ect-for-bipolar-depression/ 2025-12-31T21:00:57+00:00 https://de.pi-multilingual.rt.gw/section/take-home-points/ 2026-01-02T15:36:18+00:00 https://de.pi-multilingual.rt.gw/section/treatment-resistant-schizophrenia-should-you-consider-high-dose-olanzapine-instead-of-clozapine/ 2026-01-23T21:57:57+00:00 https://de.pi-multilingual.rt.gw/section/can-glp-1-agonists-elevate-lithium-levels/ 2026-01-23T22:36:29+00:00 https://de.pi-multilingual.rt.gw/section/antidepressant-augmentation-vs-switching-in-geriatric-depression-key-findings-from-the-optimum-trial/ 2026-01-23T22:37:58+00:00 https://de.pi-multilingual.rt.gw/section/can-inflammatory-markers-guide-antidepressant-treatment-selection/ 2026-01-23T22:46:59+00:00 https://de.pi-multilingual.rt.gw/section/panic-disorder-is-propranolol-useful-for-early-somatic-symptoms/ 2026-01-23T23:04:09+00:00 https://de.pi-multilingual.rt.gw/section/vl10113/ 2026-01-26T15:46:33+00:00 https://de.pi-multilingual.rt.gw/section/10113/ 2026-01-26T15:47:43+00:00 https://de.pi-multilingual.rt.gw/section/understanding-and-diagnosing-treatment-resistant-ocd/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/overview-of-ocd-treatment-strategies/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/managing-ocd-beyond-first-line-treatments/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/overview-of-ocd-augmentation-strategies/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/second-generation-antipsychotics-for-ocd-augmentation-third-line-agents/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/other-ocd-augmenters-buspirone-ondansetron-and-emerging-options/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/neurostimulation-for-ocd-tms-and-dbs/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/ablative-surgery-for-ocd/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/clinical-case-optimizing-ssri-before-augmentation/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/take-home-messages-5/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/glutamatergic-augmentation-in-ocd-memantine-riluzole-lamotrigine-and-other-agents/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/ssri-dosing-for-ocd-beyond-fda-guidelines/ 2026-02-01T00:00:00+00:00 https://de.pi-multilingual.rt.gw/section/how-effective-is-karxt-xanomeline-trospium-for-schizophrenia-nnt-and-nnh-explained/ 2026-03-16T23:51:55+00:00 https://de.pi-multilingual.rt.gw/section/bright-light-therapy-for-bipolar-depression-isbd-clinical-recommendations/ 2026-03-16T23:51:58+00:00 https://de.pi-multilingual.rt.gw/section/iv-haloperidol-are-cardiac-safety-concerns-overblown/ 2026-03-16T23:52:00+00:00 https://de.pi-multilingual.rt.gw/section/varenicline-and-bupropion-effective-for-treating-alcohol-use-disorder/ 2026-03-16T23:52:05+00:00 https://de.pi-multilingual.rt.gw/section/does-ashwagandha-extract-improve-cognitive-function-in-mild-cognitive-impairment/ 2026-03-16T23:52:07+00:00